<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:32:19Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8222844" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8222844</identifier>
        <datestamp>2021-06-29</datestamp>
        <setSpec>jintaidssoc</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1758-2652</journal-id>
              <journal-id journal-id-type="publisher-id">JIA2</journal-id>
              <journal-title-group>
                <journal-title>Journal of the International AIDS Society</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1758-2652</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8222844</article-id>
              <article-id pub-id-type="pmcid">PMC8222844</article-id>
              <article-id pub-id-type="pmc-uid">8222844</article-id>
              <article-id pub-id-type="pmid">34164929</article-id>
              <article-id pub-id-type="doi">10.1002/jia2.25731</article-id>
              <article-id pub-id-type="publisher-id">JIA225731</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Supplement: Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial</article-title>
                <alt-title alt-title-type="left-running-head">Velloza J et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jia225731-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Velloza</surname>
                    <given-names>Jennifer</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7242-7415</contrib-id>
                  <xref ref-type="aff" rid="jia225731-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>jvelloza@uw.edu</email>
                  </address>
                </contrib>
                <contrib id="jia225731-cr-0002" contrib-type="author">
                  <name>
                    <surname>Hosek</surname>
                    <given-names>Sybil</given-names>
                  </name>
                  <address>
                    <email>sybilhosek@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0003" contrib-type="author">
                  <name>
                    <surname>Donnell</surname>
                    <given-names>Deborah</given-names>
                  </name>
                  <address>
                    <email>deborah@scharp.org</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jia225731-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0004" contrib-type="author">
                  <name>
                    <surname>Anderson</surname>
                    <given-names>Peter L</given-names>
                  </name>
                  <address>
                    <email>peter.anderson@cuanschutz.edu</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0005" contrib-type="author">
                  <name>
                    <surname>Chirenje</surname>
                    <given-names>Mike</given-names>
                  </name>
                  <address>
                    <email>mchirenje@uzchs-ctrc.org</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0006" contrib-type="author">
                  <name>
                    <surname>Mgodi</surname>
                    <given-names>Nyaradzo</given-names>
                  </name>
                  <address>
                    <email>nmgodi@uzchs-ctrc.org</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0007" contrib-type="author">
                  <name>
                    <surname>Bekker</surname>
                    <given-names>Linda‐Gail</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0755-4386</contrib-id>
                  <address>
                    <email>linda-gail.bekker@hiv-research.org.za</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0008" contrib-type="author">
                  <name>
                    <surname>Delany‐Moretlwe</surname>
                    <given-names>Sinead</given-names>
                  </name>
                  <address>
                    <email>sdelany@wrhi.ac.za</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0009" contrib-type="author">
                  <name>
                    <surname>Celum</surname>
                    <given-names>Connie</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8813-3419</contrib-id>
                  <address>
                    <email>ccelum@uw.edu</email>
                  </address>
                  <xref ref-type="aff" rid="jia225731-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jia225731-aff-0008">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="jia225731-cr-0010" contrib-type="author">
                  <collab collab-type="authors">HPTN 082 study group</collab>
                </contrib>
              </contrib-group>
              <aff id="jia225731-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <institution>University of Washington</institution>
                <named-content content-type="organisation-division">Department of Global Health</named-content>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225731-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <institution>Stroger Hospital of Cook County</institution>
                <named-content content-type="organisation-division">Department of Psychiatry</named-content>
                <city>Chicago</city>
                <named-content content-type="country-part">IL</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225731-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Vaccine and Infectious Disease Division</named-content>
                <institution>Fred Hutchinson Cancer Research Center</institution>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225731-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Pharmaceutical Sciences</named-content>
                <institution>University of Colorado</institution>
                <city>Aurora</city>
                <named-content content-type="country-part">CO</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225731-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <institution>University of Zimbabwe College of Health Sciences Clinical Trials Research Centre</institution>
                <city>Harare</city>
                <country country="ZW">Zimbabwe</country>
              </aff>
              <aff id="jia225731-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">The Desmond Tutu HIV Centre</named-content>
                <institution>University of Cape Town</institution>
                <city>Cape Town</city>
                <country country="ZA">South Africa</country>
              </aff>
              <aff id="jia225731-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">Wits Reproductive Health &amp; HIV Institute (Wits RHI)</named-content>
                <named-content content-type="organisation-division">Faculty of Health Sciences</named-content>
                <institution>University of the Witwatersrand</institution>
                <city>Johannesburg</city>
                <country country="ZA">South Africa</country>
              </aff>
              <aff id="jia225731-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <named-content content-type="organisation-division">Department of Medicine</named-content>
                <institution>University of Washington</institution>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Corresponding author:</bold> Jennifer Velloza, University of Washington, Department of Global Health, 325 Ninth Avenue, Seattle, Washington 98104, USA. Tel: +917‐392‐3561. (<email>jvelloza@uw.edu</email>)<break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>24</day>
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <volume>24</volume>
              <issue>Suppl 2</issue>
              <issue-id pub-id-type="doi">10.1002/jia2.v24.s2</issue-id>
              <issue-title content-type="special-issue-title">Global Mental Health and HIV Prevention and Care. Guest Editors: Robert H Remien, Melanie Amna Abas, Vikram Patel, Dixon Chibanda</issue-title>
              <elocation-id>e25731</elocation-id>
              <history>
                <date date-type="rev-recd">
                  <day>13</day>
                  <month>4</month>
                  <year>2021</year>
                </date>
                <date date-type="received">
                  <day>05</day>
                  <month>10</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>20</day>
                  <month>4</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright">&#x000a9; 2021 International AIDS Society<copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2021 The Authors. Journal of the International AIDS Society published by John Wiley &amp; Sons Ltd on behalf of International AIDS Society</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JIA2-24-e25731.pdf"/>
              <abstract id="jia225731-abs-0001">
                <title>Abstract</title>
                <sec id="jia225731-sec-0001">
                  <title>Introduction</title>
                  <p>African adolescent girls and young women (AGYW) eligible for HIV pre‐exposure prophylaxis (PrEP) experience high levels of depressive symptoms. Depression can reduce PrEP adherence among adults, although analyses have considered depression as a time‐varying exposure rather than modelling distinct patterns of symptoms. The association between depressive symptoms and PrEP adherence has not been explored for AGYW. To address these gaps, we sought to understand depressive symptom trajectories among African AGYW initiating PrEP and the impact of time‐varying depressive symptoms and symptom trajectories on PrEP adherence.</p>
                </sec>
                <sec id="jia225731-sec-0002">
                  <title>Methods</title>
                  <p>HPTN 082 was an open‐label PrEP study among AGYW (ages 16 to 24) in Zimbabwe and South Africa from 2016 to 2018. Depressive symptoms were measured at enrolment and Weeks 13, 26 and 52, using the 10‐item Center for Epidemiologic Studies scale; a score ≥10 is indicative of elevated depressive symptoms. PrEP adherence was defined as any detectable tenofovir diphosphate (TFV‐DP) levels. Group‐based trajectory modelling was used to model longitudinal patterns of depressive symptoms. We assessed psychosocial and behavioural predictors of depressive symptom trajectory membership (e.g. PrEP stigma, intimate partner violence [IPV], sexual behaviour). We modelled associations between (1) group trajectory membership and PrEP adherence at Week 52 and (2) time‐varying depressive symptoms and PrEP adherence through follow‐up.</p>
                </sec>
                <sec id="jia225731-sec-0003">
                  <title>Results</title>
                  <p>At enrolment, 179 (41.9%) participants had elevated depressive symptoms. Group‐based trajectory models revealed persistent elevated depressive symptoms in 48.5%, declining symptoms in 9.4% and no consistent or mild depressive symptoms in 43.3%. AGYW who engaged in transactional sex, reported IPV, or had traumatic stress symptoms were more likely to be assigned to the persistent elevated symptom group compared with the consistent no/mild symptom group (Wald test <italic>p</italic>‐value all &lt;0.01). Participants assigned to the persistent elevated depressive symptom trajectory had a significantly lower risk of detectable TFV‐DP at Week 52 than those in the no/mild symptom trajectory (adjusted prevalence ratio = 0.89; 95% CI: 0.80 to 0.98). Elevated depressive symptoms were significantly inversely associated with PrEP use throughout follow‐up (adjusted relative risk = 0.73; 95% CI = 0.53 to 0.99).</p>
                </sec>
                <sec id="jia225731-sec-0004">
                  <title>Conclusions</title>
                  <p>Persistent depressive symptoms were common among African AGYW seeking PrEP. Integration of depressive symptom screening and treatment into PrEP programmes may improve PrEP effectiveness among African women.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd id="jia225731-kwd-0001">depression</kwd>
                <kwd id="jia225731-kwd-0002">psychosocial</kwd>
                <kwd id="jia225731-kwd-0003">HIV</kwd>
                <kwd id="jia225731-kwd-0004">pre‐exposure prophylaxis</kwd>
                <kwd id="jia225731-kwd-0005">Africa</kwd>
                <kwd id="jia225731-kwd-0006">women</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute of Allergy and Infectious Diseases </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000060</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>T32 AI007140‐42</award-id>
                  <award-id>UM1‐AI068613</award-id>
                  <award-id>UM1‐AI068617</award-id>
                  <award-id>UM1‐AI068619</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute of Mental Health </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000025</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K99MH123369</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="4"/>
                <page-count count="11"/>
                <word-count count="9810"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>June 2021</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.2 mode:remove_FC converted:24.06.2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="jia225731-cit-1001"><string-name><surname>Velloza</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hosek</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Donnell</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Anderson</surname>, <given-names>P. L.</given-names></string-name>, <string-name><surname>Chirenje</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mgodi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bekker</surname>, <given-names>L.‐G.</given-names></string-name>, <string-name><surname>Delany‐Moretlwe</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Celum</surname>, <given-names>C.</given-names></string-name>
<article-title>Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2021</year>; <volume>24</volume>(S2):<elocation-id>e25731</elocation-id>
</mixed-citation>
              </p>
              <fn-group id="jia225731-ntgp-0001">
                <fn id="jia225731-note-0001">
                  <p>Clinicaltrials.gov ID number: NCT02732730</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jia225731-body-0001">
            <sec id="jia225731-sec-0005">
              <label>1</label>
              <title>Introduction</title>
              <p>African adolescent girls and young women (AGYW) ages 15 to 24 face high rates of HIV. Recent trials among AGYW ages 18 to 25 years report HIV incidence rates as high as 7 per 100 person‐years [<xref rid="jia225731-bib-0001" ref-type="ref">1</xref>, <xref rid="jia225731-bib-0002" ref-type="ref">2</xref>, <xref rid="jia225731-bib-0003" ref-type="ref">3</xref>]. HIV pre‐exposure prophylaxis (PrEP) is a highly efficacious HIV prevention strategy being scaled up for high‐risk populations including AGYW in HIV endemic settings [<xref rid="jia225731-bib-0004" ref-type="ref">4</xref>, <xref rid="jia225731-bib-0005" ref-type="ref">5</xref>, <xref rid="jia225731-bib-0006" ref-type="ref">6</xref>, <xref rid="jia225731-bib-0007" ref-type="ref">7</xref>, <xref rid="jia225731-bib-0008" ref-type="ref">8</xref>, <xref rid="jia225731-bib-0009" ref-type="ref">9</xref>]. Demonstration projects with adolescents report high initial PrEP uptake but declines in adherence and continuation in real‐world settings [<xref rid="jia225731-bib-0010" ref-type="ref">10</xref>, <xref rid="jia225731-bib-0011" ref-type="ref">11</xref>, <xref rid="jia225731-bib-0012" ref-type="ref">12</xref>]. Lower PrEP adherence over time among AGYW is associated with complex psychosocial and behavioural factors such as lack of social support, intimate partner violence (IPV) and PrEP stigma [<xref rid="jia225731-bib-0013" ref-type="ref">13</xref>, <xref rid="jia225731-bib-0014" ref-type="ref">14</xref>, <xref rid="jia225731-bib-0015" ref-type="ref">15</xref>, <xref rid="jia225731-bib-0016" ref-type="ref">16</xref>].</p>
              <p>AGYW at risk of HIV also face high levels of depression [<xref rid="jia225731-bib-0015" ref-type="ref">15</xref>, <xref rid="jia225731-bib-0016" ref-type="ref">16</xref>]. Studies in sub‐Saharan African cohorts found that approximately 20% to 50% of young women initiating HIV prevention services have mild‐to‐moderate depressive symptoms [<xref rid="jia225731-bib-0014" ref-type="ref">14</xref>, <xref rid="jia225731-bib-0016" ref-type="ref">16</xref>, <xref rid="jia225731-bib-0017" ref-type="ref">17</xref>]. Individual and interpersonal (e.g. IPV, stigma, low social support) and community‐level and structural (e.g., food insecurity, gender inequality) factors, often acting together, can cause elevated risk of depression and HIV acquisition among women [<xref rid="jia225731-bib-0017" ref-type="ref">17</xref>, <xref rid="jia225731-bib-0018" ref-type="ref">18</xref>, <xref rid="jia225731-bib-0019" ref-type="ref">19</xref>]. PrEP trials with South African, Kenyan and Ugandan women estimated that those with depressive symptoms had 25% to 27% lower PrEP adherence than those without symptoms and this relationship persists after adjusting for IPV, social support and stigma [<xref rid="jia225731-bib-0014" ref-type="ref">14</xref>, <xref rid="jia225731-bib-0016" ref-type="ref">16</xref>]. Negative relationships between depressive symptoms and PrEP adherence have also been reported among young men who have sex with men and transgender women, suggesting that these findings are generalizable across youth at risk for HIV [<xref rid="jia225731-bib-0020" ref-type="ref">20</xref>, <xref rid="jia225731-bib-0021" ref-type="ref">21</xref>]. The HIV treatment and contraceptive fields also consistently report negative associations between depressive symptoms and medication adherence among young women in the United States and Africa [<xref rid="jia225731-bib-0022" ref-type="ref">22</xref>, <xref rid="jia225731-bib-0023" ref-type="ref">23</xref>, <xref rid="jia225731-bib-0024" ref-type="ref">24</xref>, <xref rid="jia225731-bib-0025" ref-type="ref">25</xref>, <xref rid="jia225731-bib-0026" ref-type="ref">26</xref>, <xref rid="jia225731-bib-0027" ref-type="ref">27</xref>].</p>
              <p>While prior research has explored associations between depressive symptoms and PrEP adherence in adult women, gaps remain in understanding distinct patterns of depressive symptoms over time and whether various trajectories of depressive symptom severity differentially impact PrEP use among AGYW. Depressive symptoms could change dynamically over time and recur, particularly among AGYW [<xref rid="jia225731-bib-0017" ref-type="ref">17</xref>, <xref rid="jia225731-bib-0028" ref-type="ref">28</xref>], and a nuanced view of depressive symptom patterns and how different patterns influence PrEP adherence is needed. Several studies have explored depressive symptom trajectories among adults in South Africa and the United States [<xref rid="jia225731-bib-0029" ref-type="ref">29</xref>, <xref rid="jia225731-bib-0030" ref-type="ref">30</xref>, <xref rid="jia225731-bib-0031" ref-type="ref">31</xref>], but only one analysis to date modelled symptom trajectories in AGYW and was conducted in the United States [<xref rid="jia225731-bib-0028" ref-type="ref">28</xref>]. These studies document differences between participants with distinct depressive symptom trajectories (e.g. declining, persistent, low or resurging symptoms) but did not explore associations between trajectory membership and HIV‐related outcomes. To address these gaps, we analysed data on depressive symptoms and PrEP adherence from a clinical trial of AGYW initiating PrEP in South Africa and Zimbabwe. Our objectives were to (1) model depressive symptom trajectories among African AGYW; (2) assess baseline characteristics associated with trajectory membership and (3) estimate associations between time‐varying depressive symptoms and depressive symptom trajectories on PrEP adherence. Our findings could guide future PrEP delivery efforts for African AGYW to improve both mental health and PrEP adherence outcomes in this population.</p>
            </sec>
            <sec sec-type="methods" id="jia225731-sec-0006">
              <label>2</label>
              <title>Methods</title>
              <sec id="jia225731-sec-0007">
                <label>2.1</label>
                <title>Study design and participants</title>
                <p>The HIV Prevention Trials Network (HPTN) 082 study was a randomized, open‐label trial of adherence interventions among African AGYW initiating daily oral emtricitabine tenofovir (FTC/TDF)‐based PrEP [<xref rid="jia225731-bib-0032" ref-type="ref">32</xref>]. Eligible AGYW were HIV‐negative, between 16 and 25 years old, sexually active and at high risk of HIV [<xref rid="jia225731-bib-0033" ref-type="ref">33</xref>], literate in one or more study languages and residing in Johannesburg, Cape Town or Harare. Enrolment and follow‐up occurred from 2016 to 2018.</p>
                <p>Participants were offered daily oral PrEP at enrolment. Those who accepted PrEP were randomized in 1:1 ratio to either the control group with a standard PrEP adherence package (counselling sessions, weekly SMS reminders, monthly in‐person adherence support clubs) or the intervention group (the standard package plus counselling based on PrEP drug levels, called “drug‐level feedback counselling”). Follow‐up visits took place at Weeks 4, 8, 13, 26, 39 and 52 post‐enrolment. Participants received HIV testing, counselling and PrEP refills at all visits.</p>
              </sec>
              <sec id="jia225731-sec-0008">
                <label>2.2</label>
                <title>Data collection</title>
                <p>Sociodemographic data were collected at enrolment, including age, marital status and education. At enrolment and follow‐up visits, participants completed computer‐assisted self‐interviewing (CASI) surveys to provide data on sexual behaviour (number of sex acts, condom use, number of partners, transactional sex), depressive symptoms, alcohol use, social support, stigma related to HIV and PrEP, IPV and post‐traumatic stress.</p>
                <p>Depressive symptoms were measured using the 10‐item Center for Epidemiologic Studies (CES‐D) scale at enrolment and Weeks 13, 26 and 52 [<xref rid="jia225731-bib-0034" ref-type="ref">34</xref>]. Sum scores were calculated (range 0 to 30; Cronbach’s alpha: 0.76), and a score ≥10 was indicative of elevated depressive symptoms [<xref rid="jia225731-bib-0034" ref-type="ref">34</xref>]. This cut‐off was previously used with African adolescents, enabling comparisons across studies, and has good sensitivity and sensitivity in several study languages (e.g. isiXhosa, isiZulu) [<xref rid="jia225731-bib-0034" ref-type="ref">34</xref>, <xref rid="jia225731-bib-0035" ref-type="ref">35</xref>, <xref rid="jia225731-bib-0036" ref-type="ref">36</xref>, <xref rid="jia225731-bib-0037" ref-type="ref">37</xref>, <xref rid="jia225731-bib-0038" ref-type="ref">38</xref>]. Participants were provided with referrals for mental health care with a physician, psychologist or social worker based on participant request and/or clinician discretion.</p>
                <p>Other psychosocial and behavioural variables were measured at enrolment and Weeks 13, 26 and 52. Alcohol use was measured using the three‐item AUDIT‐C scale with a score ≥3 indicative of alcohol misuse [<xref rid="jia225731-bib-0039" ref-type="ref">39</xref>]. Social support was measured with two items assessing social support from adults, adapted from prior work with young African women (Table <xref rid="jia225731-sup-0001" ref-type="supplementary-material">S1</xref>) [<xref rid="jia225731-bib-0040" ref-type="ref">40</xref>, <xref rid="jia225731-bib-0041" ref-type="ref">41</xref>]. Responses were scored from 0 to 2 and summed, with higher scores indicating higher support (range: 0 to 4). Internalized stigma related to HIV and PrEP use was assessed with six items (Table <xref rid="jia225731-sup-0001" ref-type="supplementary-material">S2</xref>), adapted from PrEP stigma questions for adults and key findings on PrEP barriers among adolescents [<xref rid="jia225731-bib-0042" ref-type="ref">42</xref>, <xref rid="jia225731-bib-0043" ref-type="ref">43</xref>, <xref rid="jia225731-bib-0044" ref-type="ref">44</xref>]. Items were scored from 0 to 4 and summed, with a higher sum score indicating greater internalized stigma (range: 0 to 24; Cronbach’s alpha: 0.89). IPV was assessed with four items (Table <xref rid="jia225731-sup-0001" ref-type="supplementary-material">S3</xref>), developed from the World Health Organization’s operational IPV definitions [<xref rid="jia225731-bib-0045" ref-type="ref">45</xref>]. Participants were considered to have experienced IPV if they answered “yes” to at least one item. Traumatic stress was assessed with the four‐item posttraumatic stress disorder (PTSD) Checklist for the DSM‐5 (PCL‐5) [<xref rid="jia225731-bib-0046" ref-type="ref">46</xref>]. An answer of “yes” to any item was considered indicative of PTSD symptoms.</p>
                <p>The primary outcome was PrEP adherence measured using intracellular tenofovir‐diphosphate levels (TFV‐DP) in dried blood spots (DBS) collected at Week 13, 26 and 52. TFV‐DP provides an estimate of cumulative PrEP dosing and has been validated among women and men who have sex with men in directly observed therapy studies [<xref rid="jia225731-bib-0047" ref-type="ref">47</xref>]. For our primary analyses, PrEP adherence was defined as detectable versus undetectable TFV‐DP levels (≥16 fmol/punch as a limit of detection), which represents any PrEP use since the prior visit [<xref rid="jia225731-bib-0047" ref-type="ref">47</xref>, <xref rid="jia225731-bib-0048" ref-type="ref">48</xref>]. We also conducted descriptive analyses of high PrEP adherence, defined as TFV‐DP levels ≥700 fmol/punch, which represents consistent dosing (≥4 PrEP doses per week) [<xref rid="jia225731-bib-0047" ref-type="ref">47</xref>, <xref rid="jia225731-bib-0048" ref-type="ref">48</xref>].</p>
              </sec>
              <sec id="jia225731-sec-0009">
                <label>2.3</label>
                <title>Group‐based trajectory modelling analysis</title>
                <p>Group‐based trajectory modelling was used to identify patterns of depressive symptoms during follow‐up. Models estimate the proportion of a population belonging to different trajectories and calculate the posterior probability of an individual belonging to an assigned trajectory given observed data. Based on similar analyses conducted with populations in the United States, we hypothesized finding depressive symptom trajectories corresponding to low symptoms, recurring symptoms, declining symptoms, and/or persistent elevated symptoms. Depressive symptoms were modelled as a binary variable (CES‐D score &lt;/≥10), using a binomial distribution.</p>
                <p>The selection of the best‐fitting trajectory model was a two‐step process. First, we identified the optimal number of trajectory groups by fitting unconditional trajectory models for depressive symptoms with 2 to 6 trajectories. This range of trajectories was decided <italic>a priori</italic> to maximize interpretability and public health utility. All trajectory groups were modelled using cubic polynomial terms in this step [<xref rid="jia225731-bib-0049" ref-type="ref">49</xref>]. We compared models using Bayesian Information Criterion (BIC) and average posterior probabilities, with average probabilities ≥0.70 indicating good fit [<xref rid="jia225731-bib-0049" ref-type="ref">49</xref>]. Second, we identified the optimal function form for each trajectory. We compared linear, quadratic and cubic terms for each trajectory and selected the functional form based on BIC values, posterior probabilities and visual inspection. We also conducted an exploratory group‐based trajectory model analysis using continuous CES‐D score following the same two‐step procedure with a censored normal distribution.</p>
                <p>After determining optimal trajectory number and form, we subsequently assessed psychosocial and behavioural characteristics associated with depressive symptom trajectory membership. Individuals were assigned to trajectories with the highest posterior probability [<xref rid="jia225731-bib-0050" ref-type="ref">50</xref>, <xref rid="jia225731-bib-0051" ref-type="ref">51</xref>]. We added covariates for study arm, site, age, education, sexual behaviour, alcohol use, social support, stigma, any IPV and PTSD symptoms. We only included baseline values of these variables to ensure the temporality of our associations. We used Wald and Wilcoxon rank sum tests to compare baseline characteristics across trajectories.</p>
                <p>Group‐based trajectory models assume missing data are missing completely at random [<xref rid="jia225731-bib-0049" ref-type="ref">49</xref>]. We compared participants with missing and complete depressive symptom data. In a sensitivity analysis, we used single mean imputation to fill in missing depressive symptom data and then repeated the two‐step modelling procedure on the complete dataset.</p>
              </sec>
              <sec id="jia225731-sec-0010">
                <label>2.4</label>
                <title>Analyses of associations between depressive symptoms and PrEP adherence</title>
                <p>We conducted two analyses of depressive symptoms and PrEP adherence. First, we estimated the association between depressive symptom trajectory group membership and PrEP adherence at Week 52 to understand how distinct depressive symptom patterns may influence PrEP use. Second, we estimated longitudinal associations between depressive symptoms and PrEP adherence to explore the effect of time‐varying symptoms on PrEP use through follow‐up.</p>
                <p>We conducted a regression analysis, with a Poisson distribution and a log link, to model prevalence ratios between assigned group trajectory membership and detectable TFV‐DP at Week 52. We also explored associations between group membership and TFV‐DP levels ≥700 fmol/punch. Any baseline factors associated with depressive symptom trajectory membership (with <italic>p</italic> &lt; 0.10) were included in the multivariable models. We included arm as a covariate to average effects across the groups with different PrEP counselling. Site was also included <italic>a priori</italic> to adjust for differences in demographics and sexual behaviour between locations [<xref rid="jia225731-bib-0032" ref-type="ref">32</xref>, <xref rid="jia225731-bib-0052" ref-type="ref">52</xref>]. We focused only on baseline variables in this analysis for ease of interpretation and to ensure temporality.</p>
                <p>We used generalized estimating equations to examine the association between longitudinal depressive symptoms and PrEP adherence. Models were fit with a log link, Poisson distribution and robust standard errors. Our primary model included elevated depressive symptoms as a categorical variable (CES‐D &lt;/≥10). We assessed time‐dependent covariates (e.g. sexual behaviour, IPV, stigma, social support). Any that resulted in a substantial change in the effect estimate (&gt;10%) were included in the multivariable model. We lagged forward depressive symptom and covariate data by one visit (e.g. depressive symptoms at enrolment were used to predict PrEP adherence at Week 13) to reduce the concern of reverse temporality.</p>
                <p>All analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC, USA) and group‐based trajectory models were estimating using PROC TRAJ [<xref rid="jia225731-bib-0051" ref-type="ref">51</xref>].</p>
              </sec>
              <sec id="jia225731-sec-0011">
                <label>2.5</label>
                <title>Ethical statement</title>
                <p>This protocol was approved by ethics review committees at each sites. All participants provided written informed consent (or assent with consent from a parent or guardian if &lt;18 years old).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="jia225731-sec-0012">
              <label>3</label>
              <title>Results</title>
              <sec id="jia225731-sec-0013">
                <label>3.1</label>
                <title>Participant characteristics</title>
                <p>Of the 427 AGYW who initiated PrEP during the study, 33.3% were from Johannesburg, 32.8% from Cape Town and 34% from Harare (Table <xref rid="jia225731-tbl-0001" ref-type="table">1</xref>). The median age was 21 years (interquartile range [IQR]: 19 to 22; range: 16 to 25). Participants reported a median of 1 sexual partner in the three months prior to enrolment (IQR: 1 to 2), although 53 (12.4%) did not answer this question. Retention was high, with an overall retention rate of 85.4% at Week 52.</p>
                <table-wrap id="jia225731-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>HPTN 082 participant characteristics at baseline (N = 427, unless otherwise indicated)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Baseline characteristics</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">Frequency<xref ref-type="fn" rid="jia225731-note-0002"><sup>a</sup></xref>
</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Arm</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Standard package</td>
                        <td align="center" rowspan="1" colspan="1">212 (49.7)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Standard package plus drug‐level feedback counselling</td>
                        <td align="center" rowspan="1" colspan="1">215 (50.4)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Study site</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Johannesburg, South Africa</td>
                        <td align="center" rowspan="1" colspan="1">142 (33.3)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cape Town, South Africa</td>
                        <td align="center" rowspan="1" colspan="1">140 (32.8)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Harare, Zimbabwe</td>
                        <td align="center" rowspan="1" colspan="1">145 (34.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, y</td>
                        <td align="center" rowspan="1" colspan="1">21.0 (19.0 to 22.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Education</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Primary school</td>
                        <td align="center" rowspan="1" colspan="1">9 (2.1)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Secondary school</td>
                        <td align="center" rowspan="1" colspan="1">371 (86.9)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">College or university</td>
                        <td align="center" rowspan="1" colspan="1">47 (11.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of sex partners in past three months (N = 372)</td>
                        <td align="center" rowspan="1" colspan="1">1.0 (1.0 to 2.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Primary sex partner in past three months (N = 425)</td>
                        <td align="center" rowspan="1" colspan="1">368 (86.6)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of vaginal sex acts (N = 338)<xref ref-type="fn" rid="jia225731-note-0003"><sup>b</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">4.0 (2.0 to 8.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Condom use with vaginal sex, past month (N = 329)<xref ref-type="fn" rid="jia225731-note-0003"><sup>b</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Always</td>
                        <td align="center" rowspan="1" colspan="1">68 (20.7)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Often</td>
                        <td align="center" rowspan="1" colspan="1">38 (11.6)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sometimes</td>
                        <td align="center" rowspan="1" colspan="1">106 (32.2)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rarely</td>
                        <td align="center" rowspan="1" colspan="1">52 (15.8)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Never</td>
                        <td align="center" rowspan="1" colspan="1">65 (19.8)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any transactional sex in the past month (N = 425)</td>
                        <td align="center" rowspan="1" colspan="1">97 (22.8)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Elevated depressive symptoms (N = 418)<xref ref-type="fn" rid="jia225731-note-0004"><sup>c</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">179 (42.8)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Alcohol misuse (N = 419)<xref ref-type="fn" rid="jia225731-note-0005"><sup>d</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">160 (38.2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Social support (N = 423)<xref ref-type="fn" rid="jia225731-note-0006"><sup>e</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (2.0 to 4.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Support from adults in your life (N = 418)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Almost never supported</td>
                        <td align="center" rowspan="1" colspan="1">23 (5.5)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sometimes supported</td>
                        <td align="center" rowspan="1" colspan="1">150 (35.9)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Very well supported</td>
                        <td align="center" rowspan="1" colspan="1">245 (58.6)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Support from close friends (N = 416)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Almost never supported</td>
                        <td align="center" rowspan="1" colspan="1">25 (6.0)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sometimes supported</td>
                        <td align="center" rowspan="1" colspan="1">215 (51.7)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Very well supported</td>
                        <td align="center" rowspan="1" colspan="1">176 (42.3)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Stigma (N = 422)<xref ref-type="fn" rid="jia225731-note-0007"><sup>f</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">6.0 (1.0 to 7.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any intimate partner violence (N = 424)<xref ref-type="fn" rid="jia225731-note-0008"><sup>g</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">209 (49.3)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Emotional intimate partner violence</td>
                        <td align="center" rowspan="1" colspan="1">157 (36.9)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Physical intimate partner violence</td>
                        <td align="center" rowspan="1" colspan="1">85 (20.0)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sexual intimate partner violence</td>
                        <td align="center" rowspan="1" colspan="1">38 (8.9)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ever felt afraid, unsafe, or in danger from a partner</td>
                        <td align="center" rowspan="1" colspan="1">79 (18.6)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Any posttraumatic stress disorder symptoms (N = 418)<xref ref-type="fn" rid="jia225731-note-0009"><sup>h</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">194 (46.4)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jia225731-ntgp-0002">
                    <fn id="jia225731-note-0002">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Data are presented as median (interquartile range) for continuous variables given variability and skewness observed in several of the variables. Data are presented as frequency (percentage) for categorical variables.</p>
                    </fn>
                    <fn id="jia225731-note-0003">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>data on number of vaginal sex acts and condom use were only collected for participants who reported any vaginal sex in the past three months</p>
                    </fn>
                    <fn id="jia225731-note-0004">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>a sum CESD‐10 score ≥10 was indicative of “elevated depressive symptoms”</p>
                    </fn>
                    <fn id="jia225731-note-0005">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>an AUDIT‐C scale score ≥3 was indicative of alcohol misuse</p>
                    </fn>
                    <fn id="jia225731-note-0006">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>social support was measured as the sum score across two items assessing social support from adults and close friends (range: 0 to 4)</p>
                    </fn>
                    <fn id="jia225731-note-0007">
                      <label>
                        <sup>f</sup>
                      </label>
                      <p>stigma was measured as the sum score across ten items assessing stigma related to HIV and PrEP use (range: 0 to 40)</p>
                    </fn>
                    <fn id="jia225731-note-0008">
                      <label>
                        <sup>g</sup>
                      </label>
                      <p>participants were considered to have experienced any intimate partner violence if they answered “yes” that they had experienced at least one of four items asking about physical, emotional, sexual violence, or feeling unsafe or in danger from a sexual partner in the past month</p>
                    </fn>
                    <fn id="jia225731-note-0009">
                      <label>
                        <sup>h</sup>
                      </label>
                      <p>a response of “yes” to any of four items from the Posttraumatic Stress Disorder (PTSD) Checklist for the DSM‐5 (PCL‐5) was indicative of PTSD symptoms.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>Overall, 41.9% of participants (N = 179) had CES‐D scores ≥10 at enrolment, and this proportion was lower during follow‐up with 33.0%, 36.7% and 36.9% reporting elevated depressive symptoms at Weeks 13, 26 and 52 respectively (<italic>p</italic>‐value for trend: 0.04; intraclass correlation coefficient: 0.39). Complete CES‐D data from all four visits were available for 320 participants. A total of 46 AGYW were missing CES‐D data at only one visit, 27 were missing data from two visits, 30 were missing data from three visits and 4 were missing from all four visits. A total of 52 AGYW (12.2%) were lost to follow‐up, defined as missing at least two CES‐D measurements without attending a subsequent visit. Missing CES‐D data were not associated with other observed data (Tables <xref rid="jia225731-sup-0001" ref-type="supplementary-material">S4,S5</xref>).</p>
              </sec>
              <sec id="jia225731-sec-0014">
                <label>3.2</label>
                <title>Group‐based trajectory model</title>
                <p>A group‐based trajectory model with three groups and linear terms had the best fit while being meaningful (Table <xref rid="jia225731-sup-0001" ref-type="supplementary-material">S6</xref>). The three groups could be described as persistent elevated depressive symptoms (47.8%), declining symptoms (8.7%) and consistent no/mild symptoms (44.4%) (Figure <xref rid="jia225731-fig-0001" ref-type="fig">1</xref>). Of the 202 participants assigned to the persistent elevated symptom trajectory, 84.7% had a ≥ 0.70 posterior probability of group membership (range: 0.54 to 0.98). Of 37 participants assigned to the declining symptom trajectory, 69.9% had a ≥ 0.70 posterior probability of membership (range: 0.49 to 0.91). Of the 188 participants assigned to the consistent no/mild symptom trajectory, 83.3% had a ≥ 0.70 posterior probability of membership (range: 0.54 to 0.91). Table <xref rid="jia225731-sup-0001" ref-type="supplementary-material">S7</xref> provides additional detail on the average predicted proportions for each trajectory. Similar results were found in an exploratory analysis with a continuous CES‐D score (Figure <xref rid="jia225731-sup-0001" ref-type="supplementary-material">S1</xref>) and a sensitivity analysis with imputed CES‐D data.</p>
                <fig fig-type="Figure" xml:lang="en" id="jia225731-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Depressive symptom trajectories for HPTN 082 participants through follow‐up (N = 423).</p>
                    <p><sup>*</sup>“Observed” data points show the average proportion of participants with elevated depressive symptoms at a given study visit; “Predicted” data points show the predicted proportion with elevated depressive symptoms in each trajectory group, as estimated from a group‐based trajectory model with assigned trajectory group determined based on each participant’s highest predicted posterior group‐membership probability.</p>
                  </caption>
                  <graphic id="jats-graphic-1" xlink:href="JIA2-24-e25731-g001"/>
                </fig>
                <p>Any transactional sex, IPV and PTSD symptoms at baseline were associated with the depressive symptom trajectory group (Table <xref rid="jia225731-tbl-0002" ref-type="table">2</xref>). Approximately 30.5% of participants in the persistent elevated depressive symptoms group reported any transactional sex, compared with 21.6% in the declining symptom group and 14.9% in the no/mild symptom group. In the persistent elevated depressive symptoms group, 62.3% reported IPV and 58.2% had PTSD symptoms. In the declining symptoms group, 54.1% reported IPV and 51.4% had PTSD symptoms and in the no/mild symptom group, 34.6% reported IPV and 33.0% reported PTSD symptoms.</p>
                <table-wrap id="jia225731-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Participant characteristics by depressive symptom trajectory group (N = 423)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="3" valign="bottom" colspan="1">Baseline characteristics</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Frequency for each depressive symptom trajesctory<xref ref-type="fn" rid="jia225731-note-0011"><sup>a</sup></xref>
</th>
                        <th align="center" rowspan="3" valign="bottom" colspan="1"><italic>p</italic>‐value<xref ref-type="fn" rid="jia225731-note-0012"><sup>b</sup></xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Consistent no/mild symptoms</th>
                        <th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Declining symptoms</th>
                        <th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Persistent elevated symptoms</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="bottom" rowspan="1" colspan="1">N = 188</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">N = 37</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">N = 202</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Standard package arm</td>
                        <td align="center" rowspan="1" colspan="1">91 (48.4)</td>
                        <td align="center" rowspan="1" colspan="1">18 (48.6)</td>
                        <td align="center" rowspan="1" colspan="1">103 (51.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.87</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, years</td>
                        <td align="center" rowspan="1" colspan="1">20.0 (19.0 to 22.0)</td>
                        <td align="center" rowspan="1" colspan="1">21.0 (20.0 to 23.0)</td>
                        <td align="center" rowspan="1" colspan="1">21.0 (19.0 to 22.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.18</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Education</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Primary school</td>
                        <td align="center" rowspan="1" colspan="1">4 (2.1)</td>
                        <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
                        <td align="center" rowspan="1" colspan="1">5 (2.5)</td>
                        <td align="center" rowspan="1" colspan="1">0.12</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Secondary school</td>
                        <td align="center" rowspan="1" colspan="1">158 (84.0)</td>
                        <td align="center" rowspan="1" colspan="1">37 (100.0)</td>
                        <td align="center" rowspan="1" colspan="1">176 (87.1)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">College or university</td>
                        <td align="center" rowspan="1" colspan="1">26 (13.8)</td>
                        <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
                        <td align="center" rowspan="1" colspan="1">21 (10.4)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of sex partners in past three months (N = 372)</td>
                        <td align="center" rowspan="1" colspan="1">1.0 (1.0 to 2.0)</td>
                        <td align="center" rowspan="1" colspan="1">1.0 (1.0 to 1.0)</td>
                        <td align="center" rowspan="1" colspan="1">1.0 (1.0 to 2.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Primary sex partner in past 3 months (N = 425)</td>
                        <td align="center" rowspan="1" colspan="1">163 (86.7)</td>
                        <td align="center" rowspan="1" colspan="1">32 (86.5)</td>
                        <td align="center" rowspan="1" colspan="1">173 (86.5)</td>
                        <td align="center" rowspan="1" colspan="1">0.99</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of vaginal sex acts (N = 338)<xref ref-type="fn" rid="jia225731-note-0013"><sup>c</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">4.0 (2.0 to 8.0)</td>
                        <td align="center" rowspan="1" colspan="1">4.0 (3.0 to 12.0)</td>
                        <td align="center" rowspan="1" colspan="1">4.0 (2.0 to 8.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.92</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Condom use with vaginal sex, past month (N = 329)<xref ref-type="fn" rid="jia225731-note-0013"><sup>c</sup></xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Always</td>
                        <td align="center" rowspan="1" colspan="1">36 (24.3)</td>
                        <td align="center" rowspan="1" colspan="1">6 (20.7)</td>
                        <td align="center" rowspan="1" colspan="1">26 (17.1)</td>
                        <td align="center" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Often</td>
                        <td align="center" rowspan="1" colspan="1">15 (10.1)</td>
                        <td align="center" rowspan="1" colspan="1">1 (3.5)</td>
                        <td align="center" rowspan="1" colspan="1">22 (14.5)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sometimes</td>
                        <td align="center" rowspan="1" colspan="1">49 (33.1)</td>
                        <td align="center" rowspan="1" colspan="1">6 (20.7)</td>
                        <td align="center" rowspan="1" colspan="1">51 (33.6)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rarely</td>
                        <td align="center" rowspan="1" colspan="1">15 (10.1)</td>
                        <td align="center" rowspan="1" colspan="1">8 (27.6)</td>
                        <td align="center" rowspan="1" colspan="1">29 (19.1)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Never</td>
                        <td align="center" rowspan="1" colspan="1">33 (22.3)</td>
                        <td align="center" rowspan="1" colspan="1">8 (27.6)</td>
                        <td align="center" rowspan="1" colspan="1">24 (15.8)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any transactional sex in the past month (N = 425)</td>
                        <td align="center" rowspan="1" colspan="1">28 (14.9)</td>
                        <td align="center" rowspan="1" colspan="1">8 (21.6)</td>
                        <td align="center" rowspan="1" colspan="1">61 (30.5)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Likely depression (N = 418)<xref ref-type="fn" rid="jia225731-note-0014"><sup>d</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">0 (0.0)</td>
                        <td align="center" rowspan="1" colspan="1">37 (100.0)</td>
                        <td align="center" rowspan="1" colspan="1">142 (72.5)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">CES‐D score<xref ref-type="fn" rid="jia225731-note-0014"><sup>d</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">5.0 (3.0 to 7.0)</td>
                        <td align="center" rowspan="1" colspan="1">12.0 (11.0 to 15.0)</td>
                        <td align="center" rowspan="1" colspan="1">11.0 (9.0 to 14.0)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Alcohol misuse (N = 419)<xref ref-type="fn" rid="jia225731-note-0015"><sup>e</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">64 (34.2)</td>
                        <td align="center" rowspan="1" colspan="1">13 (35.1)</td>
                        <td align="center" rowspan="1" colspan="1">83 (42.6)</td>
                        <td align="center" rowspan="1" colspan="1">0.23</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Social support (N = 423)<xref ref-type="fn" rid="jia225731-note-0016"><sup>f</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (2.0 to 4.0)</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (2.0 to 4.0)</td>
                        <td align="center" rowspan="1" colspan="1">3.0 (2.0 to 3.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.12</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Support from adults in your life (N = 418)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Almost never supported</td>
                        <td align="center" rowspan="1" colspan="1">12 (6.5)</td>
                        <td align="center" rowspan="1" colspan="1">1 (2.7)</td>
                        <td align="center" rowspan="1" colspan="1">10 (5.1)</td>
                        <td align="center" rowspan="1" colspan="1">0.29</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sometimes supported</td>
                        <td align="center" rowspan="1" colspan="1">56 (30.4)</td>
                        <td align="center" rowspan="1" colspan="1">14 (37.8)</td>
                        <td align="center" rowspan="1" colspan="1">80 (40.6)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Very well supported</td>
                        <td align="center" rowspan="1" colspan="1">116 (63.0)</td>
                        <td align="center" rowspan="1" colspan="1">22 (59.5)</td>
                        <td align="center" rowspan="1" colspan="1">107 (54.3)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Support from close friends (N = 416)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Almost never supported</td>
                        <td align="center" rowspan="1" colspan="1">7 (3.9)</td>
                        <td align="center" rowspan="1" colspan="1">2 (5.6)</td>
                        <td align="center" rowspan="1" colspan="1">16 (8.1)</td>
                        <td align="center" rowspan="1" colspan="1">0.13</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sometimes supported</td>
                        <td align="center" rowspan="1" colspan="1">87 (47.8)</td>
                        <td align="center" rowspan="1" colspan="1">22 (61.1)</td>
                        <td align="center" rowspan="1" colspan="1">106 (53.4)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Very well supported</td>
                        <td align="center" rowspan="1" colspan="1">88 (48.4)</td>
                        <td align="center" rowspan="1" colspan="1">12 (33.3)</td>
                        <td align="center" rowspan="1" colspan="1">76 (38.4)</td>
                        <td align="center" rowspan="1" colspan="1"> </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Stigma (N = 422)<xref ref-type="fn" rid="jia225731-note-0017"><sup>g</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">6.0 (1.0 to 7.0)</td>
                        <td align="center" rowspan="1" colspan="1">4.0 (0.0 to 8.0)</td>
                        <td align="center" rowspan="1" colspan="1">6.0 (1.0 to 8.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.53</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any intimate partner violence (N = 424)<xref ref-type="fn" rid="jia225731-note-0018"><sup>h</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">65 (34.6)</td>
                        <td align="center" rowspan="1" colspan="1">20 (54.1)</td>
                        <td align="center" rowspan="1" colspan="1">124 (62.3)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any emotional violence (N = 424)</td>
                        <td align="center" rowspan="1" colspan="1">50 (26.6)</td>
                        <td align="center" rowspan="1" colspan="1">16 (43.2)</td>
                        <td align="center" rowspan="1" colspan="1">91 (45.5)</td>
                        <td align="center" rowspan="1" colspan="1">0.01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any physical violence (N = 423)</td>
                        <td align="center" rowspan="1" colspan="1">26 (13.8)</td>
                        <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
                        <td align="center" rowspan="1" colspan="1">53 (26.5)</td>
                        <td align="center" rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any sexual violence (N = 423)</td>
                        <td align="center" rowspan="1" colspan="1">8 (4.3)</td>
                        <td align="center" rowspan="1" colspan="1">6 (16.2)</td>
                        <td align="center" rowspan="1" colspan="1">24 (12.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Ever felt afraid, unsafe, or in danger (N = 424)</td>
                        <td align="center" rowspan="1" colspan="1">16 (8.5)</td>
                        <td align="center" rowspan="1" colspan="1">11 (29.7)</td>
                        <td align="center" rowspan="1" colspan="1">52 (26.0)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Any posttraumatic stress disorder symptoms (N = 418)<xref ref-type="fn" rid="jia225731-note-0019"><sup>i</sup></xref>
</td>
                        <td align="center" rowspan="1" colspan="1">61 (33.0)</td>
                        <td align="center" rowspan="1" colspan="1">19 (51.4)</td>
                        <td align="center" rowspan="1" colspan="1">224 (58.2)</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.01</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jia225731-ntgp-0003">
                    <fn id="jia225731-note-0010">
                      <p>CES‐D=Center for Epidemiologic Studies – Depression Scale</p>
                    </fn>
                    <fn id="jia225731-note-0011">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Data are presented as median (interquartile range) for continuous variables and frequency (percentage) for categorical variables</p>
                    </fn>
                    <fn id="jia225731-note-0012">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p><italic>p</italic>‐values are based on the Wilcoxon rank sum test for continuous variables and Wald <italic>p</italic>‐values from χ<sup>2</sup> test for categorical variables</p>
                    </fn>
                    <fn id="jia225731-note-0013">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>data on number of vaginal sex acts and condom use were only collected for participants who reported any vaginal sex in the past three months</p>
                    </fn>
                    <fn id="jia225731-note-0014">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>a sum CESD‐10 score ≥10 was indicative of “likely depression”. CES‐D score is the sum value across ten CES‐D items (range: 0 to 30)</p>
                    </fn>
                    <fn id="jia225731-note-0015">
                      <label>
                        <sup>e</sup>
                      </label>
                      <p>an AUDIT‐C scale score ≥3 was indicative of alcohol misuse</p>
                    </fn>
                    <fn id="jia225731-note-0016">
                      <label>
                        <sup>f</sup>
                      </label>
                      <p>social support was measured as the sum score across two items assessing social support from adults and close friends (range: 0 to 4)</p>
                    </fn>
                    <fn id="jia225731-note-0017">
                      <label>
                        <sup>g</sup>
                      </label>
                      <p>stigma was measured as the sum score across ten items assessing stigma related to HIV and PrEP use (range: 0 to 40)</p>
                    </fn>
                    <fn id="jia225731-note-0018">
                      <label>
                        <sup>h</sup>
                      </label>
                      <p>participants were considered to have experienced any intimate partner violence if they answered “yes” that they had experienced at least one of four items asking about physical, emotional, sexual violence, or feeling unsafe or in danger from a sexual partner in the past month</p>
                    </fn>
                    <fn id="jia225731-note-0019">
                      <label>
                        <sup>i</sup>
                      </label>
                      <p>a response of “yes” to any of four items from the Posttraumatic Stress Disorder (PTSD) Checklist for the DSM‐5 (PCL‐5) was indicative of PTSD symptoms.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="jia225731-sec-0015">
                <label>3.3</label>
                <title>Associations between group membership and PrEP adherence</title>
                <p>DBS data were unavailable for 79 participants. At Week 52, 109 (31.3%) of 348 participants had detectable TFV‐DP levels. Group membership was statistically significantly associated with detectable TFV‐DP (Table <xref rid="jia225731-tbl-0003" ref-type="table">3</xref>). Participants in the persistent elevated depression symptom group were less likely to have detectable TFV‐DP levels compared with those in the consistent no/mild symptom group (adjusted prevalence ratio [aPR]: 0.89; 95% CI: 0.80 to 0.98). We were not able to explore the association between group membership and high PrEP adherence at Week 52, as only 30 participants had TFV‐DP levels ≥700 fmol/punch at the final study visit.</p>
                <table-wrap id="jia225731-tbl-0003" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Associations between depressive symptom trajectory membership and PrEP adherence at Week 52, assessed via multivariable regression models</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="3" valign="bottom" colspan="1">Exposure group</th>
                        <th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Detectable DBS TFV‐DP levels</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" rowspan="2" valign="bottom" colspan="1">Visits with detectable TFV‐DP (N = 109/348)<xref ref-type="fn" rid="jia225731-note-0022"><sup>b</sup></xref>
</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted GEE analysis<xref ref-type="fn" rid="jia225731-note-0021"><sup>a</sup></xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="bottom" rowspan="1" colspan="1">aPR (95% CI)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>p</italic>‐value</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Global <italic>p</italic>‐value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Consistent no/mild depressive symptoms</td>
                        <td align="center" rowspan="1" colspan="1">53 (35.6%)</td>
                        <td align="center" rowspan="1" colspan="1">REF</td>
                        <td align="center" rowspan="1" colspan="1">‐‐‐</td>
                        <td align="center" rowspan="3" colspan="1">0.05</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Declining depressive symptoms</td>
                        <td align="center" rowspan="1" colspan="1">12 (35.3%)</td>
                        <td align="center" rowspan="1" colspan="1">1.05 (0.46 to 2.21)</td>
                        <td align="center" rowspan="1" colspan="1">0.54</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Persistent elevated depressive symptoms</td>
                        <td align="center" rowspan="1" colspan="1">44 (26.7%)</td>
                        <td align="center" rowspan="1" colspan="1">0.89 (0.80 to 0.98)</td>
                        <td align="center" rowspan="1" colspan="1">0.04</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jia225731-ntgp-0004">
                    <fn id="jia225731-note-0020">
                      <p>PrEP=pre‐exposure prophylaxis; TFV‐DP=tenofovir diphosphate; DBS=dried blood spots; aPR=adjusted prevalence ratio</p>
                    </fn>
                    <fn id="jia225731-note-0021">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Multivariable models adjusted for study site, number of sexual partners, condom use during vaginal sex, any transactional sex, any intimate partner violence and posttraumatic stress disorder symptoms, all measured at baseline</p>
                    </fn>
                    <fn id="jia225731-note-0022">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>data are presented as median (interquartile range) for continuous variables and frequency (percentage) for categorical variables.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="jia225731-sec-0016">
                <label>3.4</label>
                <title>Associations between longitudinal depressive symptoms and PrEP adherence</title>
                <p>TFV‐DP was detected at 607 (57.9%) follow‐up visits (intra‐class correlation coefficient: 0.46). In multivariable models adjusting for site, arm and time‐varying transactional sex, IPV, PTSD symptoms, condom use, and number of sexual partners, depressive symptoms were significantly associated with detectable TFV‐DP (adjusted relative risk [aRR]: 0.73; 95% CI: 0.53 to 0.99; Table <xref rid="jia225731-tbl-0004" ref-type="table">4</xref>). High PrEP adherence (TFV‐DP levels ≥700 fmol/punch) was detected at 193 (18.4%) of follow‐up visits. Depressive symptoms were not statistically significantly associated with high PrEP adherence (Table <xref rid="jia225731-tbl-0004" ref-type="table">4</xref>).</p>
                <table-wrap id="jia225731-tbl-0004" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 4</label>
                  <caption>
                    <p>Associations between time‐varying depressive symptoms and PrEP adherence through follow‐up, assessed via generalized estimating equations</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="3" valign="bottom" colspan="1">Exposure group</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Detectable DBS TFV‐DP Levels</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">DBS TFV‐DP ≥700 fmol/punch</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" rowspan="2" valign="bottom" colspan="1">Visits with detectable TFV‐DP (N = 607/1048)<xref ref-type="fn" rid="jia225731-note-0025"><sup>b</sup></xref>
</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted GEE analysis<xref ref-type="fn" rid="jia225731-note-0024"><sup>a</sup></xref>
</th>
                        <th align="center" rowspan="2" valign="bottom" colspan="1">Visits with TFV‐DP ≥700 fmol/punch (N = 193/1048 visits)<xref ref-type="fn" rid="jia225731-note-0025"><sup>b</sup></xref>
</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted GEE analysis<xref ref-type="fn" rid="jia225731-note-0024"><sup>a</sup></xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="bottom" rowspan="1" colspan="1">aRR (95% CI)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>p</italic>‐value</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">aRR (95% CI)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>p</italic>‐value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Elevated depressive symptoms (CES‐D score ≥10)</td>
                        <td align="center" rowspan="1" colspan="1">206 (55.2%)</td>
                        <td align="center" rowspan="1" colspan="1">0.73 (0.53 to 0.99)</td>
                        <td align="center" rowspan="1" colspan="1">0.04</td>
                        <td align="center" rowspan="1" colspan="1">72 (19.3%)</td>
                        <td align="center" rowspan="1" colspan="1">1.10 (0.74 to 1.62)</td>
                        <td align="center" rowspan="1" colspan="1">0.65</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">No/mild depressive symptoms (CES‐D score &lt;10)</td>
                        <td align="center" rowspan="1" colspan="1">401 (59.4%)</td>
                        <td align="center" rowspan="1" colspan="1">REF</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                        <td align="center" rowspan="1" colspan="1">121 (17.9%)</td>
                        <td align="center" rowspan="1" colspan="1">REF</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jia225731-ntgp-0005">
                    <fn id="jia225731-note-0023">
                      <p>aRR, adjusted relative risk; CES‐D, Center for Epidemiologic Studies – Depression Scale; DBS, dried blood spots; GEE, generalized estimating equations; PrEP, pre‐exposure prophylaxis; TFV‐DP, tenofovir diphosphate.</p>
                    </fn>
                    <fn id="jia225731-note-0024">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Multivariable models adjusted for study site at baseline and time‐varying data on number of sexual partners, condom use during vaginal sex, any transactional sex, any intimate partner violence and posttraumatic stress disorder symptoms</p>
                    </fn>
                    <fn id="jia225731-note-0025">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>data are presented as median (interquartile range) for continuous variables and frequency (percentage) for categorical variables.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="discussion" id="jia225731-sec-0017">
              <label>4</label>
              <title>Discussion</title>
              <p>In this population of AGYW in South Africa and Zimbabwe, we identified three depressive symptom trajectory groups: persistent elevated depressive symptoms, declining symptoms and no/mild symptoms. Approximately 42% of our sample experienced elevated depressive symptoms at enrolment. About 90% had unchanging depressive symptoms, either as no/mild or persistent elevated symptoms, based on group‐based trajectory models fit with a linear functional form and CES‐D data from four time points. A smaller proportion was assigned to a trajectory with depressive symptoms that declined within the three months indicating that the study interventions, time on PrEP or other factors may have reduced depressive symptoms only for 9% of the population. Persistent elevated depressive symptom group membership and time‐varying depressive symptoms were significantly associated with detectable TFV‐DP levels.</p>
              <p>Ours is one of the first studies to focus on depressive symptom prevalence and patterns in a population of African AGYW seeking PrEP. Other studies with African AGYW engaged in HIV treatment, other types of prevention services, or those in nationally representative cohorts report depressive symptom prevalence estimates around 40% to 50% [<xref rid="jia225731-bib-0017" ref-type="ref">17</xref>, <xref rid="jia225731-bib-0053" ref-type="ref">53</xref>, <xref rid="jia225731-bib-0054" ref-type="ref">54</xref>]. Consistent with our findings, analyses of depressive symptom patterns among populations living with or at‐risk of HIV in the United States and South Africa also found distinct trajectories characterized by severe or persistent symptoms, declining symptoms and low or no symptoms [<xref rid="jia225731-bib-0028" ref-type="ref">28</xref>, <xref rid="jia225731-bib-0029" ref-type="ref">29</xref>, <xref rid="jia225731-bib-0030" ref-type="ref">30</xref>, <xref rid="jia225731-bib-0031" ref-type="ref">31</xref>]. Distinct from our results, several studies also found groups characterized by worsening and recurring depressive symptoms or consistent mild‐to‐moderate symptoms [<xref rid="jia225731-bib-0028" ref-type="ref">28</xref>, <xref rid="jia225731-bib-0029" ref-type="ref">29</xref>, <xref rid="jia225731-bib-0030" ref-type="ref">30</xref>, <xref rid="jia225731-bib-0031" ref-type="ref">31</xref>]. Importantly, these analyses were conducted with pregnant or recently postpartum South African adults and AGYW living with HIV in the United States. These populations likely have distinct mental health issues from African AGYW and our study adds insights on depressive symptom trajectories among African AGYW seeking PrEP. It is possible that HPTN 082 interventions may have been sufficient to prevent depressive symptoms from worsening and to address mild depressive symptoms [<xref rid="jia225731-bib-0015" ref-type="ref">15</xref>, <xref rid="jia225731-bib-0032" ref-type="ref">32</xref>]. Another HIV prevention trial with women in South Africa also found relatively stable depressive symptoms through follow‐up, with about 45% of the sample reporting symptoms consistent with depression at each study visit during a six‐month period, supporting our findings on the relative stability of more moderate‐to‐severe depressive symptoms in this population [<xref rid="jia225731-bib-0016" ref-type="ref">16</xref>].</p>
              <p>We observed significant differences in depressive symptom trajectory membership by site and baseline measures of transactional sex, IPV and symptoms of PTSD. Prior studies have also reported associations between depressive symptoms, transactional sex and other HIV risk behaviour, the combination of which may contribute to co‐occurring mental health issues and HIV among AGYW [<xref rid="jia225731-bib-0055" ref-type="ref">55</xref>, <xref rid="jia225731-bib-0056" ref-type="ref">56</xref>, <xref rid="jia225731-bib-0057" ref-type="ref">57</xref>]. For example recent work with 15‐ to 24‐year‐old AGYW in Kenya found that depressive symptoms were associated with transactional sex, intimate partner violence and HIV risk [<xref rid="jia225731-bib-0058" ref-type="ref">58</xref>]. In HPTN 082, AGYW assigned to the persistent elevated depressive symptom trajectory group were significantly more likely to report IPV and PTSD symptoms. This may have been due to repeated experiences of IPV, difficulties accessing mental health and IPV services and unmeasured contextual factors such as lack of empowerment [<xref rid="jia225731-bib-0059" ref-type="ref">59</xref>, <xref rid="jia225731-bib-0060" ref-type="ref">60</xref>, <xref rid="jia225731-bib-0061" ref-type="ref">61</xref>, <xref rid="jia225731-bib-0062" ref-type="ref">62</xref>]. Prior studies in sub‐Saharan Africa have found that IPV is associated both with a higher prevalence of depressive symptoms and PTSD symptoms, although this work has been primarily conducted with adult women [<xref rid="jia225731-bib-0063" ref-type="ref">63</xref>, <xref rid="jia225731-bib-0064" ref-type="ref">64</xref>]. We did not observe differences in depressive symptom trajectory by intervention arm, possibly because participants in both arms received some PrEP adherence counselling, support groups, SMS and referrals. The drug‐level feedback counselling intervention was not targeted at reducing depressive symptoms.</p>
              <p>We observed high drop‐offs in PrEP adherence by Week 52: only 348 (81.5%) participants had DBS samples and PrEP was detected in 31% samples at this visit. However, these results are consistent with other PrEP projects among AGYW that have reported declining PrEP adherence over time [<xref rid="jia225731-bib-0012" ref-type="ref">12</xref>, <xref rid="jia225731-bib-0065" ref-type="ref">65</xref>, <xref rid="jia225731-bib-0066" ref-type="ref">66</xref>, <xref rid="jia225731-bib-0067" ref-type="ref">67</xref>]. There are several potential mechanisms to explain our findings on the significant negative relationship between depressive symptoms and PrEP use. Depression could lead to lower self‐efficacy, healthcare engagement, reduced motivation to engage in a protective health behaviour and poorer self‐care behaviour [<xref rid="jia225731-bib-0068" ref-type="ref">68</xref>, <xref rid="jia225731-bib-0069" ref-type="ref">69</xref>, <xref rid="jia225731-bib-0070" ref-type="ref">70</xref>]. Persistent elevated depressive symptoms could also lead to social isolation over a prolonged period of time and less support to assist with PrEP pill‐taking [<xref rid="jia225731-bib-0071" ref-type="ref">71</xref>, <xref rid="jia225731-bib-0072" ref-type="ref">72</xref>, <xref rid="jia225731-bib-0073" ref-type="ref">73</xref>]. Elevated depressive symptoms could also impact needs for PrEP, as depressive symptoms have been associated with reduced frequency of sex in some cohorts but increased condomless sex in other studies with sub‐Saharan African women [<xref rid="jia225731-bib-0074" ref-type="ref">74</xref>, <xref rid="jia225731-bib-0075" ref-type="ref">75</xref>]. The impact of declining depressive symptoms on PrEP adherence is less clear. Participants in the declining depressive symptoms group had elevated depressive symptoms at enrolment which may have prevented PrEP pill‐taking habit formation early. However, it is possible that participants with declining symptoms are able to improve their PrEP use over time as their mental health improves. Future analyses with larger cohorts may be better positioned to understand this relationship between declining symptoms and PrEP adherence.</p>
              <p>Strengths of this study include a cohort with high retention and longitudinal depressive symptom measurement using a validated screening tool. We used biomarker data on PrEP adherence rather than relying on self‐report or electronic monitoring tools. However, the small sample size, particularly among participants in the declining symptom trajectory, and drop‐off in PrEP adherence could have led to imprecise estimates of group membership and associations between symptom trajectories and PrEP adherence. The sample size and length of follow‐up may have also precluded us from identifying other trajectory groups. Approximately 12% of participants declined to answer sexual behaviour items. This may have resulted in unmeasured confounding of the relationship between depressive symptoms and PrEP adherence, although we did not detect significant associations between missing sexual behaviour data, depressive symptoms and PrEP adherence. We did not systematically collect clinical data on depression treatment and cannot make conclusions on participants’ likelihood of improving with treatment. We also did not collect data on referrals given or referral visits attended. More data on depression presentation and access to counselling and pharmacotherapy would be needed to draw further conclusions. Our group trajectories are based on CES‐D results alone and clinical evaluation was not conducted. We collected data on stigma, social support and IPV using items adapted for AGYW. However, these measures have not been widely used or validated which may have impacted the quality of construct measurement and limits comparability across populations. While we included these and other variables on sexual behaviour as covariates in our models, these factors may have a bidirectional relationship with depressive symptoms and PrEP adherence and additional research is needed to understand complex pathways between depressive symptoms, other psychosocial and behavioural factors, and PrEP use. Finally, results may not be generalizable to AGYW seeking PrEP as part of real‐world service delivery.</p>
            </sec>
            <sec sec-type="conclusions" id="jia225731-sec-0018">
              <label>5</label>
              <title>Conclusions</title>
              <p>In conclusion, we found that about half of AGYW from South Africa and Zimbabwe initiating PrEP had elevated persistent depressive symptoms over one year, which was associated with lower likelihood of detectable PrEP use. Time‐varying depressive symptoms were also associated with detectable PrEP use. These findings indicate that depression assessment at PrEP initiation among African AGYW may be useful to identify women who need more intensive PrEP adherence counselling and depression treatment. While the World Health Organization currently recommends that PrEP programmes screen for mental health issues that are common causes of poor PrEP adherence [<xref rid="jia225731-bib-0009" ref-type="ref">9</xref>], our results indicate that PrEP programmes could additionally screen for factors associated with persistent elevated depressive symptoms, such as transactional sex, IPV and PTSD symptoms, to target delivery of enhanced adherence support and referrals. For example AGYW with characteristics associated with persistent elevated depressive symptoms and low PrEP adherence could be linked to evidence‐based mental health and PrEP adherence interventions to increase PrEP use and reduce depressive symptoms. Evidence‐based psychotherapy, delivered alone or alongside multi‐level HIV, sexual and reproductive health, or gender‐based violence services, can improve mental health, coping around GBV and stigma and HIV‐related outcomes among African women [<xref rid="jia225731-bib-0076" ref-type="ref">76</xref>, <xref rid="jia225731-bib-0077" ref-type="ref">77</xref>, <xref rid="jia225731-bib-0078" ref-type="ref">78</xref>, <xref rid="jia225731-bib-0079" ref-type="ref">79</xref>, <xref rid="jia225731-bib-0080" ref-type="ref">80</xref>, <xref rid="jia225731-bib-0081" ref-type="ref">81</xref>, <xref rid="jia225731-bib-0082" ref-type="ref">82</xref>]. Given the high prevalence of depression in this population who are at high risk of HIV acquisition, additional research is needed to adapt and implement effective depression treatment approaches in PrEP delivery for African AGYW. Identifying women most at risk for persistent depressive symptoms and poor PrEP adherence and providing targeted, integrated mental health and PrEP services could improve cost‐effective PrEP delivery for AGYW in HIV endemic settings.</p>
            </sec>
            <sec id="jia225731-sec-0019">
              <title>Competing interests</title>
              <p>The authors report no conflicts of interest.</p>
            </sec>
            <sec id="jia225731-sec-0020">
              <title>Authors’ contributions</title>
              <p>CC, SDM, SH, LGB, DD, NM and MC designed the parent study. JV conducted all analyses, results interpretation and wrote the first draft of the manuscript. SH, MC, NM and LGB were involved in study design, results interpretation and edited the manuscript. DD was involved in study design, statistical oversite, results interpretation and edited the manuscript. PLA was involved in study design, laboratory oversite, results interpretation and edited the manuscript. SDM and CC were involved in grant proposal development and securing funding, study design, results interpretation and edited the manuscript. All authors reviewed and approved the final version of the manuscript.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="jia225731-sup-0001">
                <caption>
                  <p><bold>Table S1</bold>. Social support measurement in HPTN 082</p>
                  <p><bold>Table S2</bold>. Stigma measurement in HPTN 082</p>
                  <p><bold>Table S3</bold>. Intimate partner violence measurement in HPTN 082</p>
                  <p><bold>Table S4</bold>. Baseline characteristics for the full participant sample compared with those who had any missed CES‐D data</p>
                  <p><bold>Table S5</bold>. Baseline characteristics for the full participant sample compared with those who were lost to follow‐up</p>
                  <p><bold>Table S6</bold>. Group‐based trajectory model fit statistics</p>
                  <p><bold>Table S7</bold>. Group‐based trajectory model output of predicted proportion with elevated depressive symptoms, by trajectory group and study visit</p>
                  <p><bold>Figure S1</bold>. Depressive symptom trajectories for HPTN 082 participants through follow‐up, using continuous CES‐D score</p>
                </caption>
                <media xlink:href="JIA2-24-e25731-s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jia225731-sec-0021">
              <title>Acknowledgements</title>
              <p>The authors thank the individuals who participated in the study, the teams at the Johannesburg, South Africa, Cape Town, South Africa and Harare, Zimbabwe study sites, and the HIV Prevention Trials Network that supported data collection and management for this work.</p>
              <sec id="jia225731-sec-0022">
                <title>Funding</title>
                <p>This work was supported by award numbers UM1‐AI068619, UM1‐AI068617, and UM1‐AI068613, from the NIH (National Institute of Allergy and Infectious Diseases [NIAID]) to HPTN. JV was supported by the NIAID of the NIH (grant T32 AI007140‐42) and by a career development award from the National Institute of Mental Health (grant K99 MH123369). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Gilead Sciences donated study medication to the NIH to support this study.</p>
              </sec>
            </ack>
            <ref-list content-type="cited-references" id="jia225731-bibl-0001">
              <title>References</title>
              <ref id="jia225731-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0001"><collab collab-type="authors">Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium</collab>
. <article-title>HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open‐label trial</article-title>. <source xml:lang="en">Lancet Lond Engl</source>. <year>2019</year>;<volume>394</volume>(<issue>10195</issue>):<fpage>303</fpage>–<lpage>13</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0002"><string-name><surname>Baeten</surname><given-names>JM</given-names></string-name>, <string-name><surname>Palanee‐Phillips</surname><given-names>T</given-names></string-name>, <string-name><surname>Brown</surname><given-names>ER</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>K</given-names></string-name>, <string-name><surname>Soto‐Torres</surname><given-names>LE</given-names></string-name>, <string-name><surname>Govender</surname><given-names>V</given-names></string-name>, et al. <article-title>Use of a vaginal ring containing dapivirine for HIV‐1 prevention in women</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2016</year>;<volume>375</volume>(<issue>22</issue>):<fpage>2121</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">26900902</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="miscellaneous" id="jia225731-cit-0003"><collab collab-type="authors">UNAIDS</collab>
. <article-title>Trend in New Infections: Eastern, Southern, Western, Central Africa by Sex</article-title>. [Internet]. <year>2018</year> [cited 2019 Jul 31]. Available from: <ext-link ext-link-type="uri" xlink:href="http://aidsinfo.unaids.org">aidsinfo.unaids.org</ext-link>
</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0004"><string-name><surname>Baggaley</surname><given-names>R</given-names></string-name>, <string-name><surname>Armstrong</surname><given-names>A</given-names></string-name>, <string-name><surname>Dodd</surname><given-names>Z</given-names></string-name>, <string-name><surname>Ngoksin</surname><given-names>E</given-names></string-name>, <string-name><surname>Krug</surname><given-names>A</given-names></string-name>. <article-title>Young key populations and HIV: a special emphasis and consideration in the new WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2015</year>;<volume>18</volume><issue>2 Suppl 1</issue>:<elocation-id>19438</elocation-id>.<pub-id pub-id-type="pmid">25724509</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0005"><string-name><surname>Grant</surname><given-names>RM</given-names></string-name>, <string-name><surname>Lama</surname><given-names>JR</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>PL</given-names></string-name>, <string-name><surname>McMahan</surname><given-names>V</given-names></string-name>, <string-name><surname>Liu</surname><given-names>AY</given-names></string-name>, <string-name><surname>Vargas</surname><given-names>L</given-names></string-name>, et al. <article-title>Preexposure chemoprophylaxis for HIV prevention in men who have sex with men</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2010</year>;<volume>363</volume>(<issue>27</issue>):<fpage>2587</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">21091279</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0006"><string-name><surname>Baeten</surname><given-names>JM</given-names></string-name>, <string-name><surname>Donnell</surname><given-names>D</given-names></string-name>, <string-name><surname>Ndase</surname><given-names>P</given-names></string-name>, <string-name><surname>Mugo</surname><given-names>NR</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>JD</given-names></string-name>, <string-name><surname>Wangisi</surname><given-names>J</given-names></string-name>, et al. <article-title>Antiretroviral prophylaxis for HIV prevention in heterosexual men and women</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2012</year>;<volume>367</volume>(<issue>5</issue>):<fpage>399</fpage>–<lpage>410</lpage>.<pub-id pub-id-type="pmid">22784037</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0007"><string-name><surname>Choopanya</surname><given-names>K</given-names></string-name>, <string-name><surname>Martin</surname><given-names>M</given-names></string-name>, <string-name><surname>Suntharasamai</surname><given-names>P</given-names></string-name>, <string-name><surname>Sangkum</surname><given-names>U</given-names></string-name>, <string-name><surname>Mock</surname><given-names>PA</given-names></string-name>, <string-name><surname>Leethochawalit</surname><given-names>M</given-names></string-name>, et al. <article-title>Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double‐blind, placebo‐controlled phase 3 trial</article-title>. <source xml:lang="en">Lancet</source>. <year>2013</year>;<volume>381</volume>(<issue>9883</issue>):<fpage>2083</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">23769234</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0008"><string-name><surname>Thigpen</surname><given-names>MC</given-names></string-name>, <string-name><surname>Kebaabetswe</surname><given-names>PM</given-names></string-name>, <string-name><surname>Paxton</surname><given-names>LA</given-names></string-name>, <string-name><surname>Smith</surname><given-names>DK</given-names></string-name>, <string-name><surname>Rose</surname><given-names>CE</given-names></string-name>, <string-name><surname>Segolodi</surname><given-names>TM</given-names></string-name>, et al. <article-title>Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2012</year>;<volume>367</volume>(<issue>5</issue>):<fpage>423</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">22784038</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="book" id="jia225731-cit-0009"><collab collab-type="authors">WHO implementation tool for pre‐exposure prophylaxis (PrEP) of HIV infection</collab>
. <source xml:lang="en">Module 12: Adolescents and young adults</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2018</year>.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0010"><string-name><surname>Bekker</surname><given-names>LG</given-names></string-name>, <string-name><surname>Roux</surname><given-names>S</given-names></string-name>, <string-name><surname>Sebastien</surname><given-names>E</given-names></string-name>, <string-name><surname>Yola</surname><given-names>N</given-names></string-name>, <string-name><surname>Amico</surname><given-names>KR</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>JP</given-names></string-name>, et al. <article-title>Daily and non‐daily pre‐exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open‐label, phase 2 trial</article-title>. <source xml:lang="en">Lancet HIV</source>. <year>2017</year>;<volume>5</volume>(<issue>2</issue>):<fpage>e68</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">28986029</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0011"><string-name><surname>Hosek</surname><given-names>SG</given-names></string-name>, <string-name><surname>Rudy</surname><given-names>B</given-names></string-name>, <string-name><surname>Landovitz</surname><given-names>R</given-names></string-name>, <string-name><surname>Kapogiannis</surname><given-names>B</given-names></string-name>, <string-name><surname>Siberry</surname><given-names>G</given-names></string-name>, <string-name><surname>Rutledge</surname><given-names>B</given-names></string-name>, et al. <article-title>An HIV preexposure prophylaxis demonstration project and safety study for young MSM</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2017</year>;<volume>74</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">27632233</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="miscellaneous" id="jia225731-cit-0012"><string-name><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>J</given-names></string-name>, <string-name><surname>Gray</surname><given-names>G</given-names></string-name>, <string-name><surname>Pidwell</surname><given-names>T</given-names></string-name>, <string-name><surname>Kayamba</surname><given-names>E</given-names></string-name>, <string-name><surname>Bennie</surname><given-names>T</given-names></string-name>, et al. <article-title>Pluspills: an open label, safety and feasibility study of oral pre‐exposure prophylaxis (PrEP) in 15‐19 year old adolescents in two sites in South Africa. Abstract #TUAC0207LB</article-title>. 9th International AIDS Society Conference (IAS) on HIV Science; July 23‐26, <year>2017</year>; Paris, France.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0013"><string-name><surname>Amico</surname><given-names>KR</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>M</given-names></string-name>, <string-name><surname>Bekker</surname><given-names>LG</given-names></string-name>, <string-name><surname>Roux</surname><given-names>S</given-names></string-name>, <string-name><surname>Atujuna</surname><given-names>M</given-names></string-name>, <string-name><surname>Sebastian</surname><given-names>E</given-names></string-name>, et al. <article-title>Experiences with HPTN 067/ADAPT study‐provided open‐label PrEP among women in Cape Town: facilitators and barriers within a mutuality framework</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2017</year>;<volume>21</volume>(<issue>5</issue>):<fpage>1361</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">27317411</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0014"><string-name><surname>Velloza</surname><given-names>J</given-names></string-name>, <string-name><surname>Baeten</surname><given-names>JM</given-names></string-name>, <string-name><surname>Haberer</surname><given-names>J</given-names></string-name>, <string-name><surname>Ngure</surname><given-names>K</given-names></string-name>, <string-name><surname>Irungu</surname><given-names>E</given-names></string-name>, <string-name><surname>Mugo</surname><given-names>NR</given-names></string-name>, et al. <article-title>Effect of depression on adherence to oral PrEP among men and women in East Africa</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2018</year>;<volume>79</volume>(<issue>3</issue>):<fpage>330</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">30063651</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0015"><string-name><surname>Velloza</surname><given-names>J</given-names></string-name>, <string-name><surname>Khoza</surname><given-names>N</given-names></string-name>, <string-name><surname>Scorgie</surname><given-names>F</given-names></string-name>, <string-name><surname>Chitukuta</surname><given-names>M</given-names></string-name>, <string-name><surname>Mutero</surname><given-names>P</given-names></string-name>, <string-name><surname>Mutiti</surname><given-names>K</given-names></string-name>, et al. <article-title>The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2020</year>;<volume>23</volume>:<elocation-id>e25463</elocation-id>.<pub-id pub-id-type="pmid">32144874</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0016"><string-name><surname>Velloza</surname><given-names>J</given-names></string-name>, <string-name><surname>Heffron</surname><given-names>R</given-names></string-name>, <string-name><surname>Amico</surname><given-names>KR</given-names></string-name>, <string-name><surname>Rowhani‐Rahbar</surname><given-names>A</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>JP</given-names></string-name>, <string-name><surname>Li</surname><given-names>M</given-names></string-name>, et al. <article-title>The effect of depression on adherence to HIV pre‐exposure prophylaxis among high‐risk South African women in HPTN 067/ADAPT</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2020</year>;<volume>24</volume>(<issue>7</issue>):<fpage>2178</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">31955360</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0017"><string-name><surname>Goin</surname><given-names>DE</given-names></string-name>, <string-name><surname>Pearson</surname><given-names>RM</given-names></string-name>, <string-name><surname>Craske</surname><given-names>MG</given-names></string-name>, <string-name><surname>Stein</surname><given-names>A</given-names></string-name>, <string-name><surname>Pettifor</surname><given-names>A</given-names></string-name>, <string-name><surname>Lippman</surname><given-names>SA</given-names></string-name>, et al. <article-title>Depression and incident HIV in adolescent girls and young women in HPTN 068: Targets for prevention and mediating factors</article-title>. <source xml:lang="en">Am J Epidemiol</source>. <year>2020</year>;<volume>189</volume>(<issue>5</issue>):<fpage>422</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">31667490</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0018"><string-name><surname>Patel</surname><given-names>V</given-names></string-name>, <string-name><surname>Saxena</surname><given-names>S</given-names></string-name>, <string-name><surname>Lund</surname><given-names>C</given-names></string-name>, <string-name><surname>Thornicroft</surname><given-names>G</given-names></string-name>, <string-name><surname>Baingana</surname><given-names>F</given-names></string-name>, <string-name><surname>Bolton</surname><given-names>P</given-names></string-name>, et al. <article-title>The Lancet Commission on global mental health and sustainable development</article-title>. <source xml:lang="en">Lancet</source>. <year>2018</year>;<volume>392</volume>(<issue>10157</issue>):<fpage>1553</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">30314863</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0019"><string-name><surname>Lund</surname><given-names>C</given-names></string-name>, <string-name><surname>Brooke‐Sumner</surname><given-names>C</given-names></string-name>, <string-name><surname>Baingana</surname><given-names>F</given-names></string-name>, <string-name><surname>Baron</surname><given-names>EC</given-names></string-name>, <string-name><surname>Breuer</surname><given-names>E</given-names></string-name>, <string-name><surname>Chandra</surname><given-names>P</given-names></string-name>, et al. <article-title>Social determinants of mental disorders and the Sustainable Development Goals: a systematic review of reviews</article-title>. <source xml:lang="en">Lancet Psychiatry</source>. <year>2018</year>;<volume>5</volume>(<issue>4</issue>):<fpage>357</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">29580610</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0020"><string-name><surname>Mehrotra</surname><given-names>ML</given-names></string-name>, <string-name><surname>Glidden</surname><given-names>DV</given-names></string-name>, <string-name><surname>McMahan</surname><given-names>V</given-names></string-name>, <string-name><surname>Amico</surname><given-names>KR</given-names></string-name>, <string-name><surname>Hosek</surname><given-names>S</given-names></string-name>, <string-name><surname>Defechereux</surname><given-names>P</given-names></string-name>, et al. <article-title>The Effect of depressive symptoms on adherence to daily oral PrEP in men who have sex with men and transgender women: a marginal structural model analysis of the iPrEx OLE study</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2016</year>;<volume>20</volume>(<issue>7</issue>):<fpage>1527</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">27125241</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0021"><string-name><surname>Pasipanodya</surname><given-names>EC</given-names></string-name>, <string-name><surname>Jain</surname><given-names>S</given-names></string-name>, <string-name><surname>Sun</surname><given-names>X</given-names></string-name>, <string-name><surname>Blumenthal</surname><given-names>J</given-names></string-name>, <string-name><surname>Ellorin</surname><given-names>E</given-names></string-name>, <string-name><surname>Corado</surname><given-names>K</given-names></string-name>, et al. <article-title>Trajectories and predictors of longitudinal preexposure prophylaxis adherence among men who have sex with men</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2018</year>;<volume>218</volume>(<issue>10</issue>):<fpage>1551</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">30295803</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0022"><string-name><surname>Rao</surname><given-names>D</given-names></string-name>, <string-name><surname>Feldman</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Fredericksen</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Crane</surname><given-names>PK</given-names></string-name>, <string-name><surname>Simoni</surname><given-names>JM</given-names></string-name>, <string-name><surname>Kitahata</surname><given-names>MM</given-names></string-name>, et al. <article-title>A structural equation model of HIV‐related stigma, depressive symptoms, and medication adherence</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2012</year>;<volume>16</volume>(<issue>3</issue>):<fpage>711</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">21380495</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0023"><string-name><surname>Hall</surname><given-names>KS</given-names></string-name>, <string-name><surname>White</surname><given-names>KO</given-names></string-name>, <string-name><surname>Rickert</surname><given-names>VI</given-names></string-name>, <string-name><surname>Reame</surname><given-names>N</given-names></string-name>, <string-name><surname>Westhoff</surname><given-names>C</given-names></string-name>. <article-title>Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women</article-title>. <source xml:lang="en">Contraception</source>. <year>2012</year>;<volume>86</volume>(<issue>5</issue>):<fpage>518</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">22673038</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0024"><string-name><surname>Hall</surname><given-names>KS</given-names></string-name>, <string-name><surname>Kusunoki</surname><given-names>Y</given-names></string-name>, <string-name><surname>Gatny</surname><given-names>H</given-names></string-name>, <string-name><surname>Barber</surname><given-names>J</given-names></string-name>. <article-title>The risk of unintended pregnancy among young women with mental health symptoms</article-title>. <source xml:lang="en">Soc Sci Med</source>. <year>2014</year>;<volume>100</volume>:<fpage>62</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">24444840</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0025"><string-name><surname>Nakimuli‐Mpungu</surname><given-names>E</given-names></string-name>, <string-name><surname>Bass</surname><given-names>JK</given-names></string-name>, <string-name><surname>Alexandre</surname><given-names>P</given-names></string-name>, <string-name><surname>Mills</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Musisi</surname><given-names>S</given-names></string-name>, <string-name><surname>Ram</surname><given-names>M</given-names></string-name>, et al. <article-title>Depression, alcohol use and adherence to antiretroviral therapy in sub‐Saharan Africa: a systematic review</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2012</year>;<volume>16</volume>(<issue>8</issue>):<fpage>2101</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">22116638</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0026"><string-name><surname>Sheth</surname><given-names>SS</given-names></string-name>, <string-name><surname>Coleman</surname><given-names>J</given-names></string-name>, <string-name><surname>Cannon</surname><given-names>T</given-names></string-name>, <string-name><surname>Milio</surname><given-names>L</given-names></string-name>, <string-name><surname>Keller</surname><given-names>J</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>J</given-names></string-name>, et al. <article-title>Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV</article-title>. <source xml:lang="en">AIDS Care</source>. <year>2015</year>;<volume>27</volume>(<issue>3</issue>):<fpage>350</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">25616659</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0027"><string-name><surname>Smith Fawzi</surname><given-names>MC</given-names></string-name>, <string-name><surname>Ng</surname><given-names>L</given-names></string-name>, <string-name><surname>Kanyanganzi</surname><given-names>F</given-names></string-name>, <string-name><surname>Kirk</surname><given-names>C</given-names></string-name>, <string-name><surname>Bizimana</surname><given-names>J</given-names></string-name>, <string-name><surname>Cyamatare</surname><given-names>F</given-names></string-name>, et al. <article-title>Mental health and antiretroviral adherence among youth living with HIV in Rwanda</article-title>. <source xml:lang="en">Pediatrics</source>. <year>2016</year>;<volume>138</volume>:<elocation-id>e20153235</elocation-id>.<pub-id pub-id-type="pmid">27677570</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0028"><string-name><surname>Brière</surname><given-names>FN</given-names></string-name>, <string-name><surname>Rohde</surname><given-names>P</given-names></string-name>, <string-name><surname>Stice</surname><given-names>E</given-names></string-name>, <string-name><surname>Morizot</surname><given-names>J</given-names></string-name>. <article-title>Group‐based symptom trajectories in indicated prevention of adolescent depression</article-title>. <source xml:lang="en">Depress Anxiety</source>. <year>2016</year>;<volume>33</volume>(<issue>5</issue>):<fpage>444</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">26457813</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0029"><string-name><surname>Pellowski</surname><given-names>JA</given-names></string-name>, <string-name><surname>Bengtson</surname><given-names>AM</given-names></string-name>, <string-name><surname>Barnett</surname><given-names>W</given-names></string-name>, <string-name><surname>DiClemente</surname><given-names>K</given-names></string-name>, <string-name><surname>Koen</surname><given-names>N</given-names></string-name>, <string-name><surname>Zar</surname><given-names>HJ</given-names></string-name>, et al. <article-title>Perinatal depression among mothers in a South African birth cohort study: Trajectories from pregnancy to 18 months postpartum</article-title>. <source xml:lang="en">J Affect Disord</source>. <year>2019</year>;<volume>259</volume>:<fpage>279</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">31454590</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0030"><string-name><surname>Bengtson</surname><given-names>AM</given-names></string-name>, <string-name><surname>Pence</surname><given-names>BW</given-names></string-name>, <string-name><surname>Powers</surname><given-names>KA</given-names></string-name>, <string-name><surname>Weaver</surname><given-names>MA</given-names></string-name>, <string-name><surname>Mimiaga</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Gaynes</surname><given-names>BN</given-names></string-name>, et al. <article-title>Trajectories of depressive symptoms among a population of HIV‐infected men and women in routine HIV care in the United States</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>10</issue>):<fpage>3176</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">29623578</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0031"><string-name><surname>Gunzler</surname><given-names>D</given-names></string-name>, <string-name><surname>Lewis</surname><given-names>S</given-names></string-name>, <string-name><surname>Webel</surname><given-names>A</given-names></string-name>, <string-name><surname>Lavakumar</surname><given-names>M</given-names></string-name>, <string-name><surname>Gurley</surname><given-names>D</given-names></string-name>, <string-name><surname>Kulp</surname><given-names>K</given-names></string-name>, et al. <article-title>Depressive symptom trajectories among people living with HIV in a collaborative care program</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2020</year>;<volume>24</volume>(<issue>6</issue>):<fpage>1765</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">31728696</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="miscellaneous" id="jia225731-cit-0032"><string-name><surname>Celum</surname><given-names>C</given-names></string-name>, <string-name><surname>Mgodi</surname><given-names>N</given-names></string-name>, <string-name><surname>Bekker</surname><given-names>LG</given-names></string-name>, <string-name><surname>Hosek</surname><given-names>S</given-names></string-name>, <string-name><surname>Donnell</surname><given-names>D</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>PL</given-names></string-name>, et al. <article-title>PrEP adherence and effect of drug level feedback among young African women in HPTN 082. Abstract #TUAC0301</article-title>. Oral presentation at the International AIDS Society Conference (IAS); July 21‐24, <year>2019</year>; Mexico City, Mexico.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0033"><string-name><surname>Balkus</surname><given-names>JE</given-names></string-name>, <string-name><surname>Brown</surname><given-names>E</given-names></string-name>, <string-name><surname>Palanee</surname><given-names>T</given-names></string-name>, <string-name><surname>Nair</surname><given-names>G</given-names></string-name>, <string-name><surname>Gafoor</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, et al. <article-title>An empiric HIV risk scoring tool to predict HIV‐1 acquisition in African women</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2016</year>;<volume>72</volume>(<issue>3</issue>):<fpage>333</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">26918545</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0034"><string-name><surname>Baron</surname><given-names>EC</given-names></string-name>, <string-name><surname>Davies</surname><given-names>T</given-names></string-name>, <string-name><surname>Lund</surname><given-names>C</given-names></string-name>. <article-title>Validation of the 10‐item Centre for Epidemiological Studies Depression Scale (CES‐D‐10) in Zulu, Xhosa and Afrikaans populations in South Africa</article-title>. <source xml:lang="en">BMC Psychiatry</source>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>6</fpage>.<pub-id pub-id-type="pmid">28068955</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0035"><string-name><surname>Kilburn</surname><given-names>K</given-names></string-name>, <string-name><surname>Prencipe</surname><given-names>L</given-names></string-name>, <string-name><surname>Hjelm</surname><given-names>L</given-names></string-name>, <string-name><surname>Peterman</surname><given-names>A</given-names></string-name>, <string-name><surname>Handa</surname><given-names>S</given-names></string-name>, <string-name><surname>Palermo</surname><given-names>T</given-names></string-name>. <article-title>Examination of performance of the Center for Epidemiologic Studies Depression Scale Short Form 10 among African youth in poor, rural households</article-title>. <source xml:lang="en">BMC Psychiatry</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>201</fpage>.<pub-id pub-id-type="pmid">29914413</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0036"><string-name><surname>Kilburn</surname><given-names>K</given-names></string-name>, <string-name><surname>Thirumurthy</surname><given-names>H</given-names></string-name>, <string-name><surname>Halpern</surname><given-names>CT</given-names></string-name>, <string-name><surname>Pettifor</surname><given-names>A</given-names></string-name>, <string-name><surname>Handa</surname><given-names>S</given-names></string-name>. <article-title>Effects of a large‐scale unconditional cash transfer program on mental health outcomes of young people in Kenya</article-title>. <source xml:lang="en">J Adolesc Health</source>. <year>2016</year>;<volume>58</volume>(<issue>2</issue>):<fpage>223</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">26576822</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0037"><string-name><surname>Oppong Asante</surname><given-names>K</given-names></string-name>, <string-name><surname>Andoh‐Arthur</surname><given-names>J</given-names></string-name>. <article-title>Prevalence and determinants of depressive symptoms among university students in Ghana</article-title>. <source xml:lang="en">J Affect Disord</source>. <year>2015</year>;<volume>171</volume>:<fpage>161</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">25305431</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0038"><string-name><surname>Peltzer</surname><given-names>K</given-names></string-name>, <string-name><surname>Pengpid</surname><given-names>S</given-names></string-name>, <string-name><surname>Tiembre</surname><given-names>I</given-names></string-name>. <article-title>Mental health, childhood abuse and HIV sexual risk behaviour among university students in Ivory Coast</article-title>. <source xml:lang="en">Ann Gen Psychiatry</source>. <year>2013</year>;<volume>12</volume>(<issue>1</issue>):<fpage>18</fpage>.<pub-id pub-id-type="pmid">23758850</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0039"><string-name><surname>Bradley</surname><given-names>KA</given-names></string-name>, <string-name><surname>DeBenedetti</surname><given-names>AF</given-names></string-name>, <string-name><surname>Volk</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Williams</surname><given-names>EC</given-names></string-name>, <string-name><surname>Frank</surname><given-names>D</given-names></string-name>, <string-name><surname>Kivlahan</surname><given-names>DR</given-names></string-name>. <article-title>AUDIT‐C as a brief screen for alcohol misuse in primary care</article-title>. <source xml:lang="en">Alcohol Clin Exp Res</source>. <year>2007</year>;<volume>31</volume>(<issue>7</issue>):<fpage>1208</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">17451397</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0040"><string-name><surname>Cowan</surname><given-names>FM</given-names></string-name>, <string-name><surname>Davey</surname><given-names>C</given-names></string-name>, <string-name><surname>Fearon</surname><given-names>E</given-names></string-name>, <string-name><surname>Mushati</surname><given-names>P</given-names></string-name>, <string-name><surname>Dirawo</surname><given-names>J</given-names></string-name>, <string-name><surname>Chabata</surname><given-names>S</given-names></string-name>, et al. <article-title>Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH‐IRe): a cluster‐randomised trial</article-title>. <source xml:lang="en">Lancet HIV</source>. <year>2018</year>;<volume>5</volume>(<issue>8</issue>):<fpage>e417</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">30030134</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0041"><string-name><surname>Wechsberg</surname><given-names>WM</given-names></string-name>, <string-name><surname>Browne</surname><given-names>FA</given-names></string-name>, <string-name><surname>Ndirangu</surname><given-names>J</given-names></string-name>, <string-name><surname>Bonner</surname><given-names>CP</given-names></string-name>, <string-name><surname>Minnis</surname><given-names>AM</given-names></string-name>, <string-name><surname>Nyblade</surname><given-names>L</given-names></string-name>, et al. <article-title>The PrEPARE Pretoria Project: protocol for a cluster‐randomized factorial‐design trial to prevent HIV with PrEP among adolescent girls and young women in Tshwane, South Africa</article-title>. <source xml:lang="en">BMC Public Health</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>1403</fpage>.<pub-id pub-id-type="pmid">32933510</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0042"><string-name><surname>Siegler</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Wiatrek</surname><given-names>S</given-names></string-name>, <string-name><surname>Mouhanna</surname><given-names>F</given-names></string-name>, <string-name><surname>Amico</surname><given-names>KR</given-names></string-name>, <string-name><surname>Dominguez</surname><given-names>K</given-names></string-name>, <string-name><surname>Jones</surname><given-names>J</given-names></string-name>, et al. <article-title>Validation of the HIV pre‐exposure prophylaxis stigma scale: performance of likert and semantic differential scale versions</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2020</year>;<volume>24</volume>(<issue>9</issue>):<fpage>2637</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="pmid">32157490</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0043"><string-name><surname>Golub</surname><given-names>SA</given-names></string-name>, <string-name><surname>Gamarel</surname><given-names>KE</given-names></string-name>, <string-name><surname>Rendina</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Surace</surname><given-names>A</given-names></string-name>, <string-name><surname>Lelutiu‐Weinberger</surname><given-names>CL</given-names></string-name>. <article-title>from efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City</article-title>. <source xml:lang="en">AIDS Patient Care STDs</source>. <year>2013</year>;<volume>27</volume>(<issue>4</issue>):<fpage>248</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">23565928</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0044"><string-name><surname>Calabrese</surname><given-names>SK</given-names></string-name>, <string-name><surname>Dovidio</surname><given-names>JF</given-names></string-name>, <string-name><surname>Tekeste</surname><given-names>M</given-names></string-name>, <string-name><surname>Taggart</surname><given-names>T</given-names></string-name>, <string-name><surname>Galvao</surname><given-names>RW</given-names></string-name>, <string-name><surname>Safon</surname><given-names>CB</given-names></string-name>, et al. <article-title>HIV pre‐exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend Planned Parenthood</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2018</year>;<volume>79</volume>(<issue>1</issue>):<fpage>46</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">29847480</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0045"><string-name><surname>Abramsky</surname><given-names>T</given-names></string-name>, <string-name><surname>Watts</surname><given-names>CH</given-names></string-name>, <string-name><surname>Garcia‐Moreno</surname><given-names>C</given-names></string-name>, <string-name><surname>Devries</surname><given-names>K</given-names></string-name>, <string-name><surname>Kiss</surname><given-names>L</given-names></string-name>, <string-name><surname>Ellsberg</surname><given-names>M</given-names></string-name>, et al. <article-title>What factors are associated with recent intimate partner violence? findings from the WHO multi‐country study on women’s health and domestic violence</article-title>. <source xml:lang="en">BMC Public Health</source>. <year>2011</year>;<volume>11</volume>:<fpage>109</fpage>.<pub-id pub-id-type="pmid">21324186</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0046"><string-name><surname>Geier</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>JC</given-names></string-name>, <string-name><surname>Hanson</surname><given-names>JL</given-names></string-name>, <string-name><surname>Heyrman</surname><given-names>K</given-names></string-name>, <string-name><surname>Larsen</surname><given-names>SE</given-names></string-name>, <string-name><surname>Brasel</surname><given-names>KJ</given-names></string-name>, et al. <article-title>Validation of abbreviated four‐ and eight‐item versions of the PTSD checklist for DSM‐5 in a traumatically injured sample</article-title>. <source xml:lang="en">J Trauma Stress</source>. <year>2020</year>;<volume>33</volume>(<issue>3</issue>):<fpage>218</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">32277772</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0047">
                <label>47</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0047"><string-name><surname>Anderson</surname><given-names>PL</given-names></string-name>, <string-name><surname>Liu</surname><given-names>AY</given-names></string-name>, <string-name><surname>Castillo‐Mancilla</surname><given-names>JR</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>EM</given-names></string-name>, <string-name><surname>Seifert</surname><given-names>SM</given-names></string-name>, <string-name><surname>McHugh</surname><given-names>C</given-names></string-name>, et al. <article-title>Intracellular tenofovir‐diphosphate and emtricitabine‐triphosphate in dried blood spots following directly observed therapy</article-title>. <source xml:lang="en">Antimicrob Agents Chemother</source>. <year>2018</year>;<volume>62</volume>(<issue>1</issue>):<fpage>e01710</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">29038282</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0048">
                <label>48</label>
                <mixed-citation publication-type="miscellaneous" id="jia225731-cit-0048"><string-name><surname>Anderson</surname><given-names>P</given-names></string-name>, <string-name><surname>Liu</surname><given-names>AY</given-names></string-name>, <string-name><surname>Castillo‐Mancilla</surname><given-names>J</given-names></string-name>, <string-name><surname>Seifert</surname><given-names>S</given-names></string-name>, <string-name><surname>McHugh</surname><given-names>C</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>T</given-names></string-name>, et al. <article-title>TFV‐DP in dried blood spots (DBS) following directly observed therapy: DOT‐DBS study</article-title>. Abstract #419. Oral presentation at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017; February 13‐16, <year>2017</year>; Seattle, WA, USA.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0049">
                <label>49</label>
                <mixed-citation publication-type="book" id="jia225731-cit-0049"><string-name><surname>Nagin</surname><given-names>D</given-names></string-name>. <source xml:lang="en">Group‐based modeling of development</source>. <publisher-loc>Cambridge, UK</publisher-loc>: <publisher-name>Harvard University Press</publisher-name>; <year>2005</year>.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0050">
                <label>50</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0050"><string-name><surname>Nagin</surname><given-names>DS</given-names></string-name>, <string-name><surname>Odgers</surname><given-names>CL</given-names></string-name>. <article-title>Group‐based trajectory modeling in clinical research</article-title>. <source xml:lang="en">Annu Rev Clin Psychol</source>. <year>2010</year>;<volume>6</volume>:<fpage>109</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">20192788</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0051">
                <label>51</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0051"><string-name><surname>Jones</surname><given-names>BL</given-names></string-name>, <string-name><surname>Nagin</surname><given-names>DS</given-names></string-name>. <article-title>Advances in group‐based trajectory modeling and an SAS procedure for estimating them</article-title>. <source xml:lang="en">Sociol Methods Res</source>. <year>2007</year>;<volume>35</volume>(<issue>4</issue>):<fpage>542</fpage>–<lpage>71</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0052">
                <label>52</label>
                <mixed-citation publication-type="miscellaneous" id="jia225731-cit-0052"><string-name><surname>Celum</surname><given-names>CL</given-names></string-name>, <string-name><surname>Delany‐Moretlwe</surname><given-names>S</given-names></string-name>, <string-name><surname>Hosek</surname><given-names>SG</given-names></string-name>, <string-name><surname>Dye</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Bekker</surname><given-names>LG</given-names></string-name>, <string-name><surname>Mgodi</surname><given-names>NM</given-names></string-name>, et al. <article-title>Risk behavior, perception, and reasons for PrEP among young African women in HPTN 082</article-title>. Abstract #1049. Oral presentation at the Conference on Retroviruses and Opportunistic Infections 2018 (CROI); March 4‐7, <year>2018</year>; Boston, MA.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0053">
                <label>53</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0053"><string-name><surname>Nabunya</surname><given-names>P</given-names></string-name>, <string-name><surname>Damulira</surname><given-names>C</given-names></string-name>, <string-name><surname>Byansi</surname><given-names>W</given-names></string-name>, <string-name><surname>Muwanga</surname><given-names>J</given-names></string-name>, <string-name><surname>Bahar</surname><given-names>OS</given-names></string-name>, <string-name><surname>Namuwonge</surname><given-names>F</given-names></string-name>, et al. <article-title>Prevalence and correlates of depressive symptoms among high school adolescent girls in southern Uganda</article-title>. <source xml:lang="en">BMC Public Health</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>1792</fpage>.<pub-id pub-id-type="pmid">33238965</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0054">
                <label>54</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0054"><string-name><surname>Jesson</surname><given-names>J</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>J</given-names></string-name>, <string-name><surname>Beksinska</surname><given-names>M</given-names></string-name>, <string-name><surname>Closson</surname><given-names>K</given-names></string-name>, <string-name><surname>Nduna</surname><given-names>M</given-names></string-name>, <string-name><surname>Smit</surname><given-names>J</given-names></string-name>, et al. <article-title>Food insecurity and depression: a cross‐sectional study of a multi‐site urban youth cohort in Durban and Soweto, South Africa</article-title>. <source xml:lang="en">Trop Med Int Health</source>. <year>2021</year>.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0055">
                <label>55</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0055"><string-name><surname>Garman</surname><given-names>EC</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>M</given-names></string-name>, <string-name><surname>Lund</surname><given-names>C</given-names></string-name>. <article-title>Perinatal depressive symptoms among low‐income South African women at risk of depression: trajectories and predictors</article-title>. <source xml:lang="en">BMC Pregnancy Childbirth</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>202</fpage>.<pub-id pub-id-type="pmid">31200665</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0056">
                <label>56</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0056"><string-name><surname>Pascoe</surname><given-names>SJS</given-names></string-name>, <string-name><surname>Langhaug</surname><given-names>LF</given-names></string-name>, <string-name><surname>Mavhu</surname><given-names>W</given-names></string-name>, <string-name><surname>Hargreaves</surname><given-names>J</given-names></string-name>, <string-name><surname>Jaffar</surname><given-names>S</given-names></string-name>, <string-name><surname>Hayes</surname><given-names>R</given-names></string-name>, et al. <article-title>Poverty, food insufficiency and HIV infection and sexual behaviour among young rural Zimbabwean women</article-title>. <source xml:lang="en">PLoS One</source>. <year>2015</year>;<volume>10</volume>:<elocation-id>e0115290</elocation-id>.<pub-id pub-id-type="pmid">25625868</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0057">
                <label>57</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0057"><string-name><surname>Sileo</surname><given-names>KM</given-names></string-name>, <string-name><surname>Kershaw</surname><given-names>TS</given-names></string-name>, <string-name><surname>Callands</surname><given-names>TA</given-names></string-name>. <article-title>A syndemic of psychosocial and mental health problems in Liberia: Examining the link to transactional sex among young pregnant women</article-title>. <source xml:lang="en">Glob Public Health</source>. <year>2019</year>;<volume>14</volume>(<issue>10</issue>):<fpage>1442</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">31010396</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0058">
                <label>58</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0058"><string-name><surname>Larsen</surname><given-names>A</given-names></string-name>, <string-name><surname>Kinuthia</surname><given-names>J</given-names></string-name>, <string-name><surname>Lagat</surname><given-names>H</given-names></string-name>, <string-name><surname>Sila</surname><given-names>J</given-names></string-name>, <string-name><surname>Abuna</surname><given-names>F</given-names></string-name>, <string-name><surname>Kohler</surname><given-names>P</given-names></string-name>, et al. <article-title>Depression and HIV risk behaviors among adolescent girls and young women seeking family planning services in Western Kenya</article-title>. <source xml:lang="en">Int J STD AIDS</source>. <year>2020</year>;<volume>31</volume>(<issue>7</issue>):<fpage>652</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">32538330</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0059">
                <label>59</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0059"><string-name><surname>Jewkes</surname><given-names>RK</given-names></string-name>, <string-name><surname>Dunkle</surname><given-names>K</given-names></string-name>, <string-name><surname>Nduna</surname><given-names>M</given-names></string-name>, <string-name><surname>Shai</surname><given-names>N</given-names></string-name>. <article-title>Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study</article-title>. <source xml:lang="en">Lancet</source>. <year>2010</year>;<volume>376</volume>(<issue>9734</issue>):<fpage>41</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20557928</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0060">
                <label>60</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0060"><string-name><surname>Shamu</surname><given-names>S</given-names></string-name>, <string-name><surname>Gevers</surname><given-names>A</given-names></string-name>, <string-name><surname>Mahlangu</surname><given-names>BP</given-names></string-name>, <string-name><surname>Jama Shai</surname><given-names>PN</given-names></string-name>, <string-name><surname>Chirwa</surname><given-names>ED</given-names></string-name>, <string-name><surname>Jewkes</surname><given-names>RK</given-names></string-name>. <article-title>Prevalence and risk factors for intimate partner violence among Grade 8 learners in urban South Africa: baseline analysis from the Skhokho Supporting Success cluster randomised controlled trial</article-title>. <source xml:lang="en">Int Health</source>. <year>2016</year>;<volume>8</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">26637828</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0061">
                <label>61</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0061"><string-name><surname>Shamu</surname><given-names>S</given-names></string-name>, <string-name><surname>Shamu</surname><given-names>P</given-names></string-name>, <string-name><surname>Machisa</surname><given-names>M</given-names></string-name>. <article-title>Factors associated with past year physical and sexual intimate partner violence against women in Zimbabwe: results from a national cluster‐based cross‐sectional survey</article-title>. <source xml:lang="en">Glob Health Action</source>. <year>2018</year>;<volume>11</volume>:<elocation-id>1625594</elocation-id>.<pub-id pub-id-type="pmid">31232228</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0062">
                <label>62</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0062"><string-name><surname>Devries</surname><given-names>KM</given-names></string-name>, <string-name><surname>Mak</surname><given-names>JY</given-names></string-name>, <string-name><surname>Bacchus</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Child</surname><given-names>JC</given-names></string-name>, <string-name><surname>Falder</surname><given-names>G</given-names></string-name>, <string-name><surname>Petzold</surname><given-names>M</given-names></string-name>, et al. <article-title>Intimate partner violence and incident depressive symptoms and suicide attempts: a systematic review of longitudinal studies</article-title>. <source xml:lang="en">PLoS Med</source>. <year>2013</year>;<volume>10</volume>:<elocation-id>e1001439</elocation-id>.<pub-id pub-id-type="pmid">23671407</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0063">
                <label>63</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0063"><string-name><surname>Kaminer</surname><given-names>D</given-names></string-name>, <string-name><surname>Grimsrud</surname><given-names>A</given-names></string-name>, <string-name><surname>Myer</surname><given-names>L</given-names></string-name>, <string-name><surname>Stein</surname><given-names>D</given-names></string-name>, <string-name><surname>Williams</surname><given-names>D</given-names></string-name>. <article-title>Risk for posttraumatic stress disorder associated with different forms of interpersonal violence in South Africa</article-title>. <source xml:lang="en">Soc Sci Med</source>. <year>2008</year>;<volume>67</volume>(<issue>10</issue>):<fpage>1589</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">18774211</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0064">
                <label>64</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0064"><string-name><surname>Verhey</surname><given-names>R</given-names></string-name>, <string-name><surname>Gibson</surname><given-names>L</given-names></string-name>, <string-name><surname>Brakarsh</surname><given-names>J</given-names></string-name>, <string-name><surname>Chibanda</surname><given-names>D</given-names></string-name>, <string-name><surname>Seedat</surname><given-names>S</given-names></string-name>. <article-title>Prevalence and correlates of probable post‐traumatic stress disorder and common mental disorders in a population with a high prevalence of HIV in Zimbabwe</article-title>. <source xml:lang="en">Eur J Psychotraumatology</source>. <year>2018</year>;<volume>9</volume>:<elocation-id>1536286</elocation-id>.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0065">
                <label>65</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0065"><string-name><surname>Stoner</surname><given-names>MCD</given-names></string-name>, <string-name><surname>Rucinski</surname><given-names>KB</given-names></string-name>, <string-name><surname>Giovenco</surname><given-names>D</given-names></string-name>, <string-name><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name><surname>Morton</surname><given-names>JF</given-names></string-name>, <string-name><surname>Bekker</surname><given-names>LG</given-names></string-name>, et al. <article-title>Trajectories of PrEP adherence among young women aged 16 to 25 in Cape Town, South Africa</article-title>. <source xml:lang="en">AIDS and Behavior</source>. <year>2021</year></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0066">
                <label>66</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0066"><string-name><surname>Celum</surname><given-names>CL</given-names></string-name>, <string-name><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name><surname>Morton</surname><given-names>JF</given-names></string-name>, <string-name><surname>Stein</surname><given-names>G</given-names></string-name>, <string-name><surname>Myers</surname><given-names>L</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>KK</given-names></string-name>, et al. <article-title>Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2020</year>;<volume>23</volume>:<elocation-id>e25636</elocation-id>.<pub-id pub-id-type="pmid">33247553</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0067">
                <label>67</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0067"><string-name><surname>Gill</surname><given-names>K</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>L</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>J</given-names></string-name>, <string-name><surname>Myer</surname><given-names>L</given-names></string-name>, <string-name><surname>Marcus</surname><given-names>R</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>M</given-names></string-name>, et al. <article-title>Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre‐exposure prophylaxis in South African adolescents: an open‐label single‐arm phase 2 trial</article-title>. <source xml:lang="en">Lancet Child Adolesc Health</source>. <year>2020</year>;<volume>4</volume>(<issue>12</issue>):<fpage>875</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">33222803</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0068">
                <label>68</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0068"><string-name><surname>Wagner</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Holloway</surname><given-names>I</given-names></string-name>, <string-name><surname>Ghosh‐Dastidar</surname><given-names>B</given-names></string-name>, <string-name><surname>Kityo</surname><given-names>C</given-names></string-name>, <string-name><surname>Mugyenyi</surname><given-names>P</given-names></string-name>. <article-title>Understanding the influence of depression on self‐efficacy, work status and condom use among HIV clients in Uganda</article-title>. <source xml:lang="en">J Psychosom Res</source>. <year>2011</year>;<volume>70</volume>(<issue>5</issue>):<fpage>440</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">21511074</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0069">
                <label>69</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0069"><string-name><surname>Crockett</surname><given-names>KB</given-names></string-name>, <string-name><surname>Entler</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Brodie</surname><given-names>E</given-names></string-name>, <string-name><surname>Kempf</surname><given-names>M‐C</given-names></string-name>, <string-name><surname>Konkle‐Parker</surname><given-names>D</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>TE</given-names></string-name>, et al. <article-title>Brief report: linking depressive symptoms to viral nonsuppression among women with HIV through adherence self‐efficacy and ART adherence</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2020</year>;<volume>83</volume>(<issue>4</issue>):<fpage>340</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">32097193</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0070">
                <label>70</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0070"><string-name><surname>Mills</surname><given-names>JC</given-names></string-name>, <string-name><surname>Pence</surname><given-names>BW</given-names></string-name>, <string-name><surname>Edmonds</surname><given-names>A</given-names></string-name>, <string-name><surname>Adedimeji</surname><given-names>A</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>RM</given-names></string-name>, <string-name><surname>Kassaye</surname><given-names>S</given-names></string-name>, et al. <article-title>The impact of cumulative depression along the HIV care continuum in women living with HIV during the era of universal antiretroviral treatment</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2019</year>;<volume>82</volume>(<issue>3</issue>):<fpage>225</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">31335585</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0071">
                <label>71</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0071"><string-name><surname>Atukunda</surname><given-names>EC</given-names></string-name>, <string-name><surname>Musiimenta</surname><given-names>A</given-names></string-name>, <string-name><surname>Musinguzi</surname><given-names>N</given-names></string-name>, <string-name><surname>Wyatt</surname><given-names>MA</given-names></string-name>, <string-name><surname>Ashaba</surname><given-names>J</given-names></string-name>, <string-name><surname>Ware</surname><given-names>NC</given-names></string-name>, et al. <article-title>Understanding patterns of social support and their relationship to an ART adherence intervention among adults in rural southwestern Uganda</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2017</year>;<volume>21</volume>(<issue>2</issue>):<fpage>428</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">27671479</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0072">
                <label>72</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0072"><string-name><surname>Turan</surname><given-names>B</given-names></string-name>, <string-name><surname>Smith</surname><given-names>W</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>MH</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>TE</given-names></string-name>, <string-name><surname>Adimora</surname><given-names>AA</given-names></string-name>, <string-name><surname>Merenstein</surname><given-names>D</given-names></string-name>, et al. <article-title>Mechanisms for the negative effects of internalized HIV‐Related stigma on antiretroviral therapy adherence in women: the mediating roles of social isolation and depression</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2016</year>;<volume>72</volume>(<issue>2</issue>):<fpage>198</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="pmid">26885803</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0073">
                <label>73</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0073"><string-name><surname>van der Straten</surname><given-names>A</given-names></string-name>, <string-name><surname>Stadler</surname><given-names>J</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>E</given-names></string-name>, <string-name><surname>Hartmann</surname><given-names>M</given-names></string-name>, <string-name><surname>Magazi</surname><given-names>B</given-names></string-name>, <string-name><surname>Mathebula</surname><given-names>F</given-names></string-name>, et al. <article-title>Women’s experiences with oral and vaginal pre‐exposure prophylaxis: the VOICE‐C qualitative study in Johannesburg, South Africa</article-title>. <source xml:lang="en">PLoS One</source>. <year>2014</year>;<volume>9</volume>:<elocation-id>e89118</elocation-id>.<pub-id pub-id-type="pmid">24586534</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0074">
                <label>74</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0074"><string-name><surname>Kiene</surname><given-names>SM</given-names></string-name>, <string-name><surname>Lule</surname><given-names>H</given-names></string-name>, <string-name><surname>Sileo</surname><given-names>KM</given-names></string-name>, <string-name><surname>Silmi</surname><given-names>KP</given-names></string-name>, <string-name><surname>Wanyenze</surname><given-names>RK</given-names></string-name>. <article-title>Depression, alcohol use, and intimate partner violence among outpatients in rural Uganda: vulnerabilities for HIV, STIs and high risk sexual behavior</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>88</fpage>.<pub-id pub-id-type="pmid">28103834</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0075">
                <label>75</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0075"><string-name><surname>Frohlich</surname><given-names>P</given-names></string-name>, <string-name><surname>Meston</surname><given-names>C</given-names></string-name>. <article-title>Sexual functioning and self‐reported depressive symptoms among college women</article-title>. <source xml:lang="en">J Sex Res</source>. <year>2002</year>;<volume>39</volume>(<issue>4</issue>):<fpage>321</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">12545415</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0076">
                <label>76</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0076"><string-name><surname>Sikkema</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Dennis</surname><given-names>AC</given-names></string-name>, <string-name><surname>Watt</surname><given-names>MH</given-names></string-name>, <string-name><surname>Choi</surname><given-names>KW</given-names></string-name>, <string-name><surname>Yemeke</surname><given-names>TT</given-names></string-name>, <string-name><surname>Joska</surname><given-names>JA</given-names></string-name>. <article-title>Improving mental health among people living with HIV: a review of intervention trials in low‐ and middle‐income countries</article-title>. <source xml:lang="en">Glob Ment Health</source>. <year>2015</year>;<volume>2</volume>:<elocation-id>e19</elocation-id>.</mixed-citation>
              </ref>
              <ref id="jia225731-bib-0077">
                <label>77</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0077"><string-name><surname>Andersen</surname><given-names>LS</given-names></string-name>, <string-name><surname>Magidson</surname><given-names>JF</given-names></string-name>, <string-name><surname>O’Cleirigh</surname><given-names>C</given-names></string-name>, <string-name><surname>Remmert</surname><given-names>JE</given-names></string-name>, <string-name><surname>Kagee</surname><given-names>A</given-names></string-name>, <string-name><surname>Leaver</surname><given-names>M</given-names></string-name>, et al. <article-title>A pilot study of a nurse‐delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa</article-title>. <source xml:lang="en">J Health Psychol</source>. <year>2016</year>;<volume>23</volume>(<issue>6</issue>):<fpage>776</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="pmid">27121977</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0078">
                <label>78</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0078"><string-name><surname>Petersen</surname><given-names>I</given-names></string-name>, <string-name><surname>Hanass Hancock</surname><given-names>J</given-names></string-name>, <string-name><surname>Bhana</surname><given-names>A</given-names></string-name>, <string-name><surname>Govender</surname><given-names>K</given-names></string-name>. <article-title>A group‐based counselling intervention for depression comorbid with HIV/AIDS using a task shifting approach in South Africa: a randomized controlled pilot study</article-title>. <source xml:lang="en">J Affect Disord</source>. <year>2014</year>;<volume>158</volume>:<fpage>78</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">24655769</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0079">
                <label>79</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0079"><string-name><surname>Bolton</surname><given-names>P</given-names></string-name>, <string-name><surname>Bass</surname><given-names>J</given-names></string-name>, <string-name><surname>Neugebauer</surname><given-names>R</given-names></string-name>, <string-name><surname>Verdeli</surname><given-names>H</given-names></string-name>, <string-name><surname>Clougherty</surname><given-names>KF</given-names></string-name>, <string-name><surname>Wickramaratne</surname><given-names>P</given-names></string-name>, et al. <article-title>Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial</article-title>. <source xml:lang="en">JAMA</source>. <year>2003</year>;<volume>289</volume>:<elocation-id>3117</elocation-id>.<pub-id pub-id-type="pmid">12813117</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0080">
                <label>80</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0080"><string-name><surname>Abas</surname><given-names>M</given-names></string-name>, <string-name><surname>Nyamayaro</surname><given-names>P</given-names></string-name>, <string-name><surname>Bere</surname><given-names>T</given-names></string-name>, <string-name><surname>Saruchera</surname><given-names>E</given-names></string-name>, <string-name><surname>Mothobi</surname><given-names>N</given-names></string-name>, <string-name><surname>Simms</surname><given-names>V</given-names></string-name>, et al. <article-title>Feasibility and acceptability of a task‐shifted intervention to enhance adherence to HIV medication and improve depression in people living with HIV in Zimbabwe, a low income country in Sub‐Saharan Africa</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>1</issue>):<fpage>86</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">28063075</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0081">
                <label>81</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0081"><string-name><surname>Sikkema</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Mulawa</surname><given-names>MI</given-names></string-name>, <string-name><surname>Robertson</surname><given-names>C</given-names></string-name>, <string-name><surname>Watt</surname><given-names>MH</given-names></string-name>, <string-name><surname>Ciya</surname><given-names>N</given-names></string-name>, <string-name><surname>Stein</surname><given-names>DJ</given-names></string-name>, et al. <article-title>Improving AIDS Care After Trauma (ImpACT): pilot outcomes of a coping intervention among HIV‐infected women with sexual trauma in South Africa</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>3</issue>):<fpage>1039</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">29270789</pub-id></mixed-citation>
              </ref>
              <ref id="jia225731-bib-0082">
                <label>82</label>
                <mixed-citation publication-type="journal" id="jia225731-cit-0082"><string-name><surname>Sin</surname><given-names>NL</given-names></string-name>, <string-name><surname>DiMatteo</surname><given-names>MR</given-names></string-name>. <article-title>Depression treatment enhances adherence to antiretroviral therapy: a meta‐analysis</article-title>. <source xml:lang="en">Ann Behav Med</source>. <year>2014</year>;<volume>47</volume>(<issue>3</issue>):<fpage>259</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">24234601</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
